Rank,Term name,P-value,Z-score,Combined score,Overlapping genes,Adjusted p-value,Old p-value,Old adjusted p-value,gene count
1,Cytoplasmic Ribosomal Proteins WP477,7.038854409474494e-55,68.2633913340157,8511.812417437342,"['RPL4', 'RPL5', 'RPL30', 'RPL3', 'RPL32', 'RPL31', 'RPL34', 'RPLP1', 'RPLP0', 'RPL10A', 'RPL8', 'RPL9', 'RPL6', 'RPL7', 'RPS4X', 'RPS15', 'RPL7A', 'RPS14', 'RPS17', 'RPS16', 'RPL18A', 'RPS19', 'RPS18', 'RPS6KA2', 'RPL36', 'RPL35', 'RPLP2', 'RPL38', 'RPL37', 'RPS11', 'RPL39', 'RPS10', 'RPS13', 'RPS12', 'RPS9', 'RPS7', 'RPL21', 'RPS8', 'RPL23', 'RPS5', 'RPS6', 'RPL22', 'RPL13A', 'RPSA', 'RPS3A', 'RPL37A', 'RPL24', 'RPL27', 'RPL26', 'RPL29', 'RPL28', 'UBA52', 'RPL10', 'RPL12', 'RPL11', 'RPL36A', 'RPS15A', 'RPL14', 'RPS3', 'RPL13', 'RPS2', 'RPL15', 'RPS27A', 'RPL18', 'RPL17', 'RPL19', 'RPL41', 'RPL35A', 'RPL23A', 'RPS26', 'RPS25', 'RPS28', 'RPS27', 'RPS29', 'RPL27A', 'RPS20', 'FAU', 'RPS21', 'RPS24', 'RPS23']",3.892486488439395e-52,0,0,80
2,Electron Transport Chain (OXPHOS system in mitochondria) WP111,1.4731335691033372e-15,6.047475255829559,206.529653219604,"['NDUFB9', 'NDUFB8', 'NDUFB7', 'UQCRB', 'NDUFB10', 'COX4I1', 'NDUFB3', 'NDUFB2', 'ATP5MC3', 'NDUFB1', 'COX7A2', 'UQCR11', 'UQCR10', 'COX6A1', 'COX5B', 'COX7A1', 'COX7C', 'COX5A', 'UQCRH', 'ATP5MC1', 'ATP5IF1', 'ATP5F1B', 'UQCRFS1', 'ATP5MG', 'ATP5MF', 'COX8A', 'SURF1', 'NDUFA7', 'ATP5PD', 'NDUFA5', 'NDUFA4', 'NDUFA3', 'NDUFA2', 'NDUFA1', 'NDUFC2', 'COX6C', 'ATP5F1E', 'COX6B1', 'COX7A2L', 'UQCRQ', 'NDUFS6', 'NDUFS5', 'NDUFAB1', 'NDUFS3', 'ATP5PO', 'SLC25A5', 'SLC25A4']",4.073214318570727e-13,0,0,47
3,Nonalcoholic fatty liver disease WP4396,1.199104529890646e-09,3.251008064516129,66.78120239695683,"['NDUFA13', 'GSK3A', 'NDUFA11', 'IRS1', 'COX4I1', 'PIK3CD', 'IRS2', 'COX6A1', 'COX7C', 'UQCRFS1', 'COX8A', 'SREBF1', 'NDUFC2', 'COX6B1', 'TNFRSF1A', 'COX7A2L', 'NDUFS6', 'NDUFS5', 'NDUFS3', 'NDUFB9', 'NDUFB8', 'NDUFB7', 'UQCRB', 'NDUFB10', 'NDUFB11', 'NDUFB3', 'NDUFB2', 'NDUFB1', 'COX7A2', 'UQCR11', 'UQCR10', 'COX5B', 'COX7A1', 'COX5A', 'UQCRH', 'SOCS3', 'CCL2', 'XBP1', 'NDUFA7', 'NDUFA5', 'NDUFA4', 'NDUFA3', 'NDUFA2', 'NDUFA1', 'COX6C', 'UQCRQ', 'NDUFAB1', 'CYCS', 'FAS', 'BAX']",2.210349350098424e-07,0,0,50
4,Oxidative phosphorylation WP623,1.3190603412034728e-08,5.387533200531209,97.75011543575862,"['NDUFB9', 'NDUFB8', 'NDUFB7', 'NDUFA11', 'NDUFB10', 'NDUFB2', 'ATP5MC3', 'NDUFB1', 'ATP5MC1', 'ATP5F1B', 'ATP5MG', 'ATP5MF', 'NDUFA7', 'ATP5PD', 'ATP6AP1', 'NDUFA5', 'NDUFA4', 'NDUFA3', 'NDUFA2', 'NDUFC2', 'ATP5F1E', 'NDUFS6', 'NDUFS5', 'NDUFAB1', 'NDUFS3', 'ATP5PO']",1.8236009217138013e-06,0,0,26
5,Mitochondrial CIV Assembly WP4922,2.571735547379204e-07,6.866071428571429,104.18243554467973,"['COX8A', 'COX19', 'COA3', 'SURF1', 'PET100', 'NDUFA4', 'COX4I1', 'COX7A2', 'COX6A1', 'HIGD1A', 'COX5B', 'COX6C', 'COX5A', 'COX7C', 'PET117', 'COX6B1', 'PNKD', 'COX14']",2.8443395154013994e-05,0,0,18
6,Mitochondrial complex I assembly model OXPHOS system WP4324,6.350760422497907e-06,3.8981113320079523,46.64844883356658,"['NDUFB9', 'NDUFA13', 'NDUFB8', 'NDUFA7', 'NDUFB7', 'DMAC1', 'NDUFB10', 'NDUFA5', 'NDUFB11', 'NDUFA3', 'NDUFB3', 'NDUFA2', 'NDUFB2', 'NDUFA1', 'NDUFC2', 'NDUFB1', 'TMEM70', 'NDUFS6', 'NDUFS5', 'NDUFAB1', 'NDUFS3', 'NDUFAF3']",0.0005853284189402239,0,0,22
7,Synaptic Vesicle Pathway WP2267,2.5125089695383862e-05,3.923366418527709,41.55489890210018,"['NSF', 'SNAP25', 'SLC22A3', 'SLC38A1', 'RAB3A', 'UNC13A', 'SYT1', 'CACNA1B', 'CLTA', 'CACNA1A', 'SYP', 'SYN3', 'CPLX2', 'CPLX1', 'RIMS1', 'STX1B', 'AP2S1', 'SLC25A4', 'VAMP2']",0.001984882085935325,0,0,19
8,Vitamin D Receptor Pathway WP2877,6.177933125932664e-05,2.976119402985075,28.844375731333624,"['CDKN2D', 'CDKN1A', 'SERPINB1', 'GADD45A', 'SATB1', 'HILPDA', 'NFATC2', 'TNFRSF11B', 'ATP2C2', 'ATP2B1', 'CYP3A5', 'SLC8A1', 'CEACAM1', 'BCL6', 'DNER', 'CREG2', 'S100A6', 'TIMP2', 'SPP1', 'CD9', 'PRKCQ', 'IGSF9B', 'JUNB', 'CD200']",0.0038163306170208157,0,0,24
9,Nuclear Receptors Meta-Pathway WP2882,6.211026320648706e-05,1.97852427573351,19.16517189136939,"['IRS2', 'DBI', 'SLC2A3', 'AHR', 'SLC6A1', 'AKAP13', 'FTH1', 'DNER', 'ENC1', 'SLC39A7', 'JUNB', 'SLC39A1', 'SREBF1', 'HSP90AA1', 'SLC6A16', 'SLC6A15', 'SLC2A13', 'HGF', 'SLC39A11', 'AIP', 'NRG1', 'SLC39A14', 'CDC37', 'PMP2', 'ANGPTL4', 'EPHA3', 'EPHA2', 'FKBP5', 'FTL', 'GSTP1', 'MGST1', 'TXN', 'SLC5A3', 'CYP3A5', 'CYP3A7', 'CCL2', 'HES1', 'SLC19A2', 'CBR3', 'NQO1', 'GADD45B', 'SLC10A1', 'STAT3', 'SMARCA1', 'SLC2A9', 'SCD', 'FASN', 'SPINK13', 'BAX', 'SPRY1', 'GCLM', 'HSPA1A']",0.0038163306170208157,0,0,52
10,Calcium Regulation in the Cardiac Cell WP536,8.898562502840328e-05,2.3464722222222223,21.885630227520664,"['CHRM3', 'RYR2', 'RGS17', 'YWHAB', 'CHRM5', 'CAMK2A', 'CACNA1B', 'ITPR1', 'ATP1A4', 'CACNA1A', 'CACNA1D', 'ADCY2', 'PRKCZ', 'SLC8A1', 'GNAI1', 'RGS4', 'GNG3', 'PLN', 'GNG2', 'GRK5', 'PRKAR2B', 'GJA9', 'YWHAG', 'YWHAH', 'KCNB1', 'ATP1B2', 'ATP2B1', 'ATP1B1', 'YWHAZ', 'FKBP1A', 'PRKAR1A', 'CAMK4', 'PRKCQ', 'CALM3']",0.004920905064070701,0,0,34
11,Spinal Cord Injury WP2431,0.00024019031613890432,2.6441127694859037,22.036244613143513,"['RTN4R', 'IL1R1', 'GADD45A', 'XYLT1', 'MIF', 'PLA2G5', 'AQP1', 'ICAM1', 'GFAP', 'TNFSF13B', 'RHOB', 'FKBP1A', 'LGALS3', 'BCAN', 'ZFP36', 'VCAN', 'GAP43', 'COL4A1', 'APEX1', 'CCNG1', 'PLXNA2', 'CCL2', 'SLIT3', 'SLIT2']",0.012075022256801281,0,0,24
12,Complement system WP2806,0.0008821189768088263,3.57072956182308,25.11359665392985,"['LAMA5', 'C1S', 'C1R', 'PROS1', 'LAMB1', 'TXN', 'ICAM1', 'RPS19', 'C1QBP', 'SPP1', 'SERPING1', 'CD59', 'KLKB1']",0.04065098284794008,0,0,13
13,Differentiation Pathway WP2848,0.0012357775342162324,4.938765432098766,33.070244593269976,"['NT5E', 'KITLG', 'WNT2B', 'NOTCH1', 'CSF1', 'EGF', 'HGF', 'WNT7B', 'VEGFA']",0.05031374363872638,0,0,9
14,GABA receptor Signaling WP4159,0.0013633849731223692,3.8823529411764706,25.61492891572484,"['GABRA2', 'GABRB2', 'GABRA1', 'GAD1', 'GABRA4', 'AP2S1', 'GAD2', 'SLC6A1', 'GABRD', 'GABRG3', 'GABRG2']",0.05031374363872638,0,0,11
15,Cholesterol Biosynthesis Pathway WP197,0.001364748923292759,5.642645607107601,37.22331880798533,"['FDPS', 'SQLE', 'MVK', 'HMGCS1', 'CYP51A1', 'MSMO1', 'HMGCR', 'DHCR7']",0.05031374363872638,0,0,8
16,Proximal tubule transport WP4917,0.002006240397767166,3.6231669138243534,22.50527504355342,"['ATP6V1G1', 'SLC13A3', 'ATP6V0B', 'SLC1A1', 'SLC3A1', 'ATP1A1', 'ATP6V1E1', 'ATP1B1', 'ATP6V0C', 'AQP1', 'ATP6V1F']",0.06910095844542517,0,0,11
17,Gene regulatory network modelling somitogenesis  WP2854,0.0021242609287020395,12.331197634302612,75.89027600329904,"['LFNG', 'RIPPLY2', 'NOTCH1', 'HES1', 'TBX6']",0.06910095844542517,0,0,5
18,Extracellular vesicles in the crosstalk of cardiac cells WP4300,0.002579864321076186,5.757934550238447,34.31739626940281,"['EGF', 'CD81', 'STAT3', 'SPP1', 'HSPB1', 'ETS2', 'SOD1']",0.07579281345329784,0,0,7
19,Overview of nanoparticle effects WP3287,0.0026040930481241575,7.400887573964497,44.040245747049894,"['CCND3', 'COL4A1', 'LAMA3', 'FN1', 'PIK3CD', 'BAX']",0.07579281345329784,0,0,6
20,Selenium Micronutrient Network WP15,0.0032968576823071013,2.648588410104012,15.136114592900972,"['SERPINA3', 'GPX4', 'TXN', 'SOD2', 'ICAM1', 'SELENOH', 'SOD1', 'PRDX3', 'PRDX2', 'SELENOM', 'PRDX5', 'RFK', 'SELENOW', 'CCL2', 'SEPHS2']",0.09115811491579134,0,0,15
21,NRF2 pathway WP2884,0.005130449072764313,1.9800995024875623,10.44019756150206,"['NQO1', 'HSP90AA1', 'SLC6A16', 'HGF', 'SLC6A15', 'SLC2A13', 'GSTP1', 'SLC39A11', 'SLC2A3', 'NRG1', 'TXN', 'SLC6A1', 'SLC5A3', 'SLC39A14', 'SLC2A9', 'FTH1', 'SLC39A7', 'GCLM', 'SLC39A1', 'EPHA3', 'FTL', 'EPHA2', 'CBR3', 'HSPA1A']",0.13341251887035005,0,0,24
22,Cholesterol metabolism (includes both Bloch and Kandutsch-Russell pathways) WP4718,0.005548802773992859,2.5625595892922624,13.310378062508114,"['FDPS', 'SREBF1', 'MVK', 'HMGCS1', 'ELOVL4', 'CYP51A1', 'MSMO1', 'DHCR24', 'HMGCR', 'HSD17B7', 'SQLE', 'SCD', 'FASN', 'DHCR7']",0.13341251887035005,0,0,14
23,Pathogenic Escherichia coli infection WP2272,0.005548802773992859,2.5625595892922624,13.310378062508114,"['ITGB1', 'TUBB', 'ARPC5L', 'TUBB4B', 'YWHAZ', 'TUBB4A', 'ACTB', 'ACTG1', 'TUBA1B', 'TUBB2B', 'TUBA1A', 'TUBB2A', 'TUBB3', 'NCL']",0.13341251887035005,0,0,14
24,Hematopoietic Stem Cell Differentiation WP2849,0.00665299475285022,3.417777777777778,17.132254292156937,"['HES6', 'CIITA', 'KITLG', 'NOTCH1', 'CSF1', 'TRIM29', 'PIM1', 'NFATC2', 'RUNX1']",0.1495421554704347,0,0,9
25,The Overlap Between Signal Transduction Pathways that Contribute to a Range of LMNA Laminopathies WP4879,0.0067604952744319486,2.391554426496669,11.949782250868983,"['SREBF1', 'CDKN1A', 'CEBPB', 'NOTCH1', 'SMAD3', 'MAOB', 'CEBPD', 'WNT7B', 'HMGA2', 'TNFRSF11B', 'ACTB', 'SPP1', 'HES1', 'JUNB', 'HES5']",0.1495421554704347,0,0,15
26,Mitochondrial complex III assembly WP4921,0.00707946996361672,4.317587567834238,21.374460066944636,"['UQCRB', 'UQCC3', 'UQCRQ', 'UQCRFS1', 'UQCR11', 'UQCR10', 'UQCRH']",0.15057488038000177,0,0,7
27,p53 transcriptional gene network WP4963,0.007925600288106828,2.259663032705649,10.931475175793055,"['CDKN1A', 'NOTCH1', 'SIVA1', 'GLS2', 'GADD45A', 'SAT1', 'CX3CL1', 'PML', 'ICAM1', 'SESN1', 'ADGRB1', 'CCNG1', 'CCL2', 'FAS', 'BAX', 'IRF9']",0.15375410781103163,0,0,16
28,Differentiation of white and brown adipocyte WP2895,0.008434345232015956,4.932938856015779,23.55696927221462,"['SMAD1', 'CEBPB', 'ZIC1', 'SMAD9', 'SLC7A10', 'BMP7']",0.15375410781103163,0,0,6
29,Cellular Proteostasis WP4918,0.009118543849576421,9.860098522167487,46.31727201362598,"['VBP1', 'PFDN2', 'PFDN5', 'PFDN6']",0.15375410781103163,0,0,4
30,Mammary gland development pathway - Involution (Stage 4 of 4) WP2815,0.009118543849576421,9.860098522167487,46.31727201362598,"['SOCS3', 'STAT3', 'CHI3L1', 'BAX']",0.15375410781103163,0,0,4
31,Somitogenesis in the context of spondylocostal dysostosis WP4785,0.009118543849576421,9.860098522167487,46.31727201362598,"['LFNG', 'RIPPLY2', 'NOTCH1', 'TBX6']",0.15375410781103163,0,0,4
32,Aryl Hydrocarbon Receptor Pathway WP2873,0.009318766283598963,3.1733333333333333,14.837634101708888,"['NQO1', 'HSP90AA1', 'CDC37', 'MGST1', 'AIP', 'BAX', 'HES1', 'AHR', 'JUNB']",0.15375410781103163,0,0,9
33,Development and heterogeneity of the ILC family WP3893,0.009453236284945887,6.164366683095121,28.734567342087956,"['NFIL3', 'ZBTB16', 'ID2', 'IL18', 'AHR']",0.15375410781103163,0,0,5
34,Nicotine Activity on Dopaminergic Neurons WP1602,0.009453236284945887,6.164366683095121,28.734567342087956,"['GNG2', 'CDK5', 'CHRNA4', 'ADCY2', 'GNAI1']",0.15375410781103163,0,0,5
35,Adipogenesis WP236,0.012132211221245245,1.8351004956609616,8.09626387298648,"['WWTR1', 'SREBF1', 'CDKN1A', 'CEBPB', 'SMAD3', 'GADD45B', 'CEBPD', 'IRS1', 'GADD45A', 'STAT3', 'IRS2', 'AHR', 'MIF', 'BSCL2', 'SOCS3', 'KLF6', 'SCD', 'NAMPT', 'PNPLA3', 'NDN', 'ID3', 'FAS', 'RXRG']",0.19168893729567488,0,0,23
36,Glycolysis and Gluconeogenesis WP534,0.012836124559566066,2.7426438296003512,11.945562852372392,"['LDHA', 'TPI1', 'MDH1', 'MDH2', 'MPC2', 'PGAM1', 'PGK1', 'SLC2A3', 'ENO2', 'GAPDH']",0.19717713559555652,0,0,10
37,Complement and Coagulation Cascades WP558,0.015692046586799593,3.4533793783917117,14.34741439205757,"['CPB2', 'C1S', 'C1R', 'PROS1', 'SERPING1', 'F3', 'KLKB1']",0.2345324800675723,0,0,7
38,IL1 and megakaryocytes in obesity WP2865,0.01630239690556408,4.931000492853623,20.298183115452424,"['IL1R1', 'IL18', 'TIMP2', 'CCL2', 'ICAM1']",0.23724277602044566,0,0,5
39,Exercise-induced Circadian Regulation WP410,0.017829521772822043,2.213875002132778,8.915052513201596,"['HSPA8', 'CEBPB', 'RBPMS', 'CBX3', 'GSTP1', 'ETV6', 'DNAJA1', 'SUMO1', 'PPP1R3C', 'TUBB3', 'SUMO3', 'TAB2', 'ERC2']",0.24877287003844953,0,0,13
40,Dual hijack model of Vif in HIV infection WP3300,0.018444281503754847,6.572742200328407,26.244965535409538,"['UBB', 'ELOB', 'ELOC', 'RUNX1']",0.24877287003844953,0,0,4
41,Mevalonate pathway WP3963,0.018444281503754847,6.572742200328407,26.244965535409538,"['FDPS', 'MVK', 'HMGCS1', 'HMGCR']",0.24877287003844953,0,0,4
42,mBDNF and proBDNF regulation of GABA neurotransmission WP4829,0.02134444078598874,2.4678853754940713,9.493866091864515,"['GABRA2', 'GABRB2', 'GABRA1', 'SLC12A5', 'SHC1', 'GABRA4', 'STAT3', 'GABRD', 'GABRG3', 'GABRG2']",0.28103513701551835,0,0,10
43,Parkin-Ubiquitin Proteasomal System pathway WP2359,0.02366558587249007,1.9278203485701855,7.2172453491229795,"['PSMD10', 'HSPA8', 'TUBB', 'HSPA2', 'TUBB4B', 'TUBB4A', 'TUBA1B', 'TUBB2B', 'TUBA1A', 'TUBB2A', 'TUBB3', 'RNF19A', 'STUB1', 'HSPA1B', 'SNCA', 'HSPA1A']",0.3043504415694653,0,0,16
44,Cell-type Dependent Selectivity of CCK2R Signaling WP3679,0.025792999940009873,4.108756366025957,15.028401531463786,"['RYR2', 'ITPR1', 'CD38', 'CCK', 'GNAI1']",0.3241711128823968,0,0,5
45,Aryl Hydrocarbon Receptor Netpath WP2586,0.026869323315912567,2.3501317523056655,8.499886112496789,"['NQO1', 'CDKN1A', 'HSP90AA1', 'KLF6', 'PSRC1', 'CDC37', 'AIP', 'AHR', 'HRAS', 'VEGFA']",0.3301941287488811,0,0,10
46,Folate Metabolism WP176,0.028367877177097895,2.4671604938271603,8.789253977779644,"['DHFR', 'SERPINA3', 'CSF1', 'GPX4', 'RFK', 'CCL2', 'SOD2', 'ICAM1', 'SOD1']",0.34103121910728557,0,0,9
47,FGF23 signaling in hypophosphatemic rickets and related disorders WP4790,0.03201202406096131,4.929064039408867,16.96408217276527,"['CDKN1A', 'SPP1', 'FAM20C', 'FGFR3']",0.3688051938689918,0,0,4
48,Inflammatory Response Pathway WP453,0.03201202406096131,4.929064039408867,16.96408217276527,"['LAMA5', 'FN1', 'LAMB1', 'TNFRSF1A']",0.3688051938689918,0,0,4
49,Genotoxicity pathway WP4286,0.034291599719319006,2.042566253965006,6.889279518492078,"['ARRDC4', 'ACTA2', 'ITPKC', 'CDKN1A', 'RPS27', 'DAAM1', 'CEBPD', 'GADD45A', 'BLOC1S2', 'ID2', 'ITPR1', 'TRIM22']",0.38700519683231455,0,0,12
50,Arachidonate Epoxygenase / Epoxide Hydrolase WP678,0.03675602916254399,7.391432791728213,24.417250888782018,"['COX8A', 'GSTP1', 'COX5A']",0.39855066915464366,0,0,3
51,Liver X receptor pathway WP2874,0.03675602916254399,7.391432791728213,24.417250888782018,"['SREBF1', 'SCD', 'FASN']",0.39855066915464366,0,0,3
52,Cori Cycle WP1946,0.03819205765925208,3.5214391325776244,11.497948454467457,"['LDHA', 'TPI1', 'PGAM1', 'PGK1', 'GAPDH']",0.4061578439532,0,0,5
53,Vitamin B12 metabolism WP1533,0.039464814708018915,2.6556487419832266,8.583974980223026,"['SERPINA3', 'CUBN', 'CCL2', 'APOE', 'SOD2', 'ICAM1', 'SOD1']",0.4117743874251785,0,0,7
54,Ferroptosis WP4313,0.040831637200861984,2.1453428424127856,6.861445886249477,"['MAP1LC3A', 'GPX4', 'FTH1', 'PCBP1', 'ACSL6', 'GCLM', 'SAT1', 'CP', 'SLC39A14', 'FTL']",0.4181462105940125,0,0,10
55,Sudden Infant Death Syndrome (SIDS) Susceptibility Pathways WP706,0.042478753029191546,1.5786369412674734,4.986521422232229,"['RYR2', 'SNAP25', 'GABRA1', 'CEBPB', 'TSPYL1', 'CAV3', 'CHRNA4', 'YWHAB', 'CHRNA7', 'ATP1A3', 'YWHAZ', 'VEGFA', 'PRKAR1A', 'PRKAR2B', 'PAH', 'PLP1', 'HES1', 'GAPDH', 'SLC25A4', 'YWHAG', 'VAMP2', 'HES5', 'YWHAH']",0.4271045531844168,0,0,23
56,"GPCRs, Class C Metabotropic glutamate, pheromone WP501",0.050059080399062365,3.942857142857143,11.807088231738257,"['GRM3', 'GRM5', 'GRM8', 'GRM1']",0.4856609028189735,0,0,4
57,NOTCH1 regulation of endothelial cell calcification WP3413,0.050059080399062365,3.942857142857143,11.807088231738257,"['NOTCH1', 'SAT1', 'FGFR3', 'VEGFA']",0.4856609028189735,0,0,4
58,Globo Sphingolipid Metabolism WP1424,0.05316081840655024,2.6893491124260356,7.891716532365545,"['ST6GAL1', 'ST6GAL2', 'ST8SIA1', 'FUT2', 'A4GALT', 'ST6GALNAC5']",0.4982700437088523,0,0,6
59,Striated Muscle Contraction Pathway WP383,0.05316081840655024,2.6893491124260356,7.891716532365545,"['ACTA2', 'ACTN2', 'TPM3', 'TPM2', 'TCAP', 'ACTG1']",0.4982700437088523,0,0,6
60,"GPCRs, Class A Rhodopsin-like WP455",0.05907567360551962,1.9733201581027668,5.582396540209671,"['P2RY12', 'CHRM3', 'EDNRA', 'P2RY14', 'GPR87', 'GPR171', 'CHRM5', 'ACKR4', 'GPR37L1', 'NTSR2']",0.49915596394807354,0,0,10
61,Nucleotide-binding Oligomerization Domain (NOD) pathway WP1433,0.06407523492151465,2.301101792468344,6.322731275124022,"['NDUFA13', 'HSP90AA1', 'ACAP1', 'IL18', 'ERBIN', 'NOD1', 'NLRP1']",0.49915596394807354,0,0,7
62,Type II interferon signaling (IFNG) WP619,0.06407523492151465,2.301101792468344,6.322731275124022,"['SOCS3', 'CIITA', 'HLA-B', 'GBP1', 'IRF9', 'ICAM1', 'PSMB9']",0.49915596394807354,0,0,7
63,Biogenic Amine Synthesis WP550,0.06439355513743224,4.92712949286066,13.513843651373202,"['GAD1', 'PAH', 'GAD2']",0.49915596394807354,0,0,3
64,Farnesoid X receptor pathway WP2879,0.06439355513743224,4.92712949286066,13.513843651373202,"['SLC10A1', 'IRS2', 'FKBP5']",0.49915596394807354,0,0,3
65,HIF1A and PPARG regulation of glycolysis WP2456,0.06439355513743224,4.92712949286066,13.513843651373202,"['LDHA', 'TPI1', 'GAPDH']",0.49915596394807354,0,0,3
66,miRNA regulation of DNA damage response WP1530,0.06794355684914737,1.7338085240113938,4.662346297138389,"['CDKN1A', 'GADD45B', 'GADD45A', 'TNFRSF10B', 'PML', 'CCND3', 'CCND2', 'CDK5', 'SESN1', 'CCNG1', 'FAS', 'CYCS', 'BAX']",0.49915596394807354,0,0,13
67,Common Pathways Underlying Drug Addiction WP2636,0.06991247206665113,1.8972332015810276,5.047610216692716,"['GRIN2A', 'GRM5', 'CAMK4', 'CAMK2A', 'GNAI1', 'GRM1', 'ACTB', 'GRIA3', 'ACTG1', 'GRIA4']",0.49915596394807354,0,0,10
68,Photodynamic therapy-induced NF-kB survival signaling WP3617,0.0722220459646857,2.7383494879798476,7.196409656957479,"['TRAF6', 'BCL2L2', 'ICAM1', 'VEGFA', 'TNFRSF1A']",0.49915596394807354,0,0,5
69,Computational Model of Aerobic Glycolysis WP4629,0.07256355941773975,3.285385878489327,8.618527870365254,"['LDHA', 'TPI1', 'PGK1', 'GAPDH']",0.49915596394807354,0,0,4
70,FOXA2 pathway WP5066,0.07256355941773975,3.285385878489327,8.618527870365254,"['SREBF1', 'IRS1', 'FASN', 'IRS2']",0.49915596394807354,0,0,4
71,ID signaling pathway WP53,0.07256355941773975,3.285385878489327,8.618527870365254,"['SREBF1', 'ID2', 'ID3', 'ELK3']",0.49915596394807354,0,0,4
72,Mevalonate arm of cholesterol biosynthesis pathway WP4190,0.07256355941773975,3.285385878489327,8.618527870365254,"['FDPS', 'MVK', 'HMGCS1', 'HMGCR']",0.49915596394807354,0,0,4
73,miR-509-3p alteration of YAP1/ECM axis WP3967,0.07256355941773975,3.285385878489327,8.618527870365254,"['EDNRA', 'PBX3', 'FN1', 'TEAD3']",0.49915596394807354,0,0,4
74,Benzene metabolism WP3891,0.07590548358244774,9.851377952755906,25.39947627403494,"['NQO1', 'EPHX1']",0.49915596394807354,0,0,2
75,Drug Induction of Bile Acid Pathway WP2289,0.07590548358244774,9.851377952755906,25.39947627403494,"['SLC10A1', 'SLC51A']",0.49915596394807354,0,0,2
76,SARS-CoV-2 altering angiogenesis via NRP1 WP5065,0.07590548358244774,9.851377952755906,25.39947627403494,"['NRP1', 'VEGFA']",0.49915596394807354,0,0,2
77,Myometrial relaxation and contraction pathways WP289,0.07613048964310565,1.4456497997815798,3.7229912422734603,"['RYR2', 'RGS17', 'YWHAB', 'CAMK2A', 'ITPR1', 'ADCY2', 'PRKCZ', 'YWHAZ', 'SLC8A1', 'ETS2', 'ACTB', 'ACTG1', 'RGS4', 'ACTA2', 'GNG3', 'GNG2', 'GRK5', 'PRKAR1A', 'PRKAR2B', 'PLCG2', 'PRKCQ', 'CALM3', 'YWHAG', 'YWHAH']",0.49915596394807354,0,0,24
78,VEGFA-VEGFR2 Signaling Pathway WP3888,0.07726996010087288,1.2253395126921214,3.1374205716879833,"['ITGB1', 'RPL5', 'ARPC5L', 'PLOD3', 'HSPB1', 'NRARP', 'PTPRJ', 'SHB', 'RPL10A', 'ETS1', 'SLC8A1', 'RPL7', 'ICAM1', 'ACTG1', 'RPL18A', 'ADAMTS1', 'TMSB4X', 'CFL1', 'RPLP2', 'SH3BGRL3', 'ELOC', 'ATP6V1E1', 'RPS11', 'IER5', 'TMSB10', 'HRAS', 'HSP90AA1', 'TPM3', 'RPS6', 'RPL13A', 'F3', 'EPN1', 'RCN1', 'NCL', 'TXNIP', 'MYH9', 'RPL27', 'RPL26', 'PFN1', 'GAPDH', 'VCL', 'ARF6', 'EPHA2', 'SHC1', 'EPB41', 'PLA2G5', 'TXN', 'PRKCZ', 'NDRG1', 'APOLD1', 'PRDX2', 'LDHA', 'PAK1', 'AP2S1', 'PGK1', 'CCL2', 'SDF2L1', 'STAT3', 'FN1', 'NFATC2', 'NFATC1', 'BMX', 'SOD2', 'RAB11A', 'VEGFA', 'DNAJA1', 'P4HA2', 'RCAN2', 'FAS', 'CYCS', 'HSPA1A']",0.49915596394807354,0,0,71
79,Disruption of postsynaptic signaling by CNV WP4875,0.07776587505611603,1.9298550724637682,4.928951303652991,"['RPH3A', 'RYR2', 'GRIN2A', 'CAMK2A', 'NRXN3', 'DLGAP1', 'GRM1', 'YWHAG', 'SHANK1']",0.49915596394807354,0,0,9
80,Lung fibrosis WP3624,0.07920800676321041,2.157067094227923,5.469627337598145,"['CEBPB', 'EGF', 'HGF', 'SPP1', 'CCL2', 'ATP11A', 'BMP7']",0.49915596394807354,0,0,7
81,Focal Adhesion WP306,0.08155377106590021,1.3725327123530717,3.44024323583698,"['ITGB1', 'LAMA5', 'SHC1', 'RASGRF1', 'LAMA3', 'PIK3CD', 'ACTB', 'MYL12B', 'ACTG1', 'IGF1R', 'PAK1', 'CCND3', 'CCND2', 'SPP1', 'FLNA', 'TNR', 'PAK3', 'HRAS', 'VASP', 'CAV3', 'ITGA3', 'EGF', 'ACTN1', 'HGF', 'FN1', 'LAMB1', 'VEGFA', 'MYL5', 'COL4A1', 'VCL']",0.49915596394807354,0,0,30
82,Ectoderm Differentiation WP2858,0.08308966087615476,1.4280884732961698,3.5528484908434903,"['ELOVL4', 'TSC22D1', 'FZD4', 'ZBTB16', 'ARHGDIG', 'HMGB2', 'TNFRSF11B', 'NFATC1', 'SORCS1', 'RRBP1', 'JAKMIP1', 'CDH8', 'CLDN11', 'TRPM2', 'PODXL', 'BOC', 'PIM1', 'RHPN1', 'PLXNA2', 'CCL2', 'KIFC3', 'LY6E', 'SNCA', 'CLVS1']",0.49915596394807354,0,0,24
83,Ebola Virus Pathway on Host WP4217,0.08634002852701263,1.4603597741441197,3.5770957124190734,"['ITGB1', 'CAV3', 'ITGA3', 'ACTN1', 'HLA-B', 'CLTB', 'HLA-C', 'CLTA', 'PIK3CD', 'ACTB', 'ASGR1', 'IGF1R', 'ACTG1', 'HLA-E', 'RHOB', 'SOCS3', 'PAK1', 'C1QBP', 'NEDD4', 'IRF7', 'FLNA']",0.49915596394807354,0,0,21
84,"GPCRs, Other WP117",0.0866654042621467,2.275147928994083,5.564330434219215,"['CHRM3', 'EDNRA', 'GRM8', 'GRM1', 'ADGRL2', 'GPR135']",0.49915596394807354,0,0,6
85,PKC-gamma calcium signaling pathway in ataxia WP4760,0.0866654042621467,2.275147928994083,5.564330434219215,"['GNA14', 'ITPR1', 'CACNA1A', 'GRM1', 'GRIA3', 'GRIA4']",0.49915596394807354,0,0,6
86,Apoptosis Modulation and Signaling WP1772,0.08944315779873685,1.5748790743258196,3.801997410129002,"['TNFRSF6B', 'IL1R1', 'TNFRSF10B', 'TNFRSF11B', 'TNFRSF1A', 'CAPNS1', 'BAG3', 'TRAF6', 'TOLLIP', 'FAS', 'CYCS', 'BAX', 'MAP3K14', 'BCL2L2', 'HSPA1A']",0.49915596394807354,0,0,15
87,Prolactin Signaling Pathway WP2037,0.08944315779873685,1.5748790743258196,3.801997410129002,"['ITGB1', 'IRS1', 'SHC1', 'RPS6', 'STAT3', 'IRS2', 'GAB2', 'YWHAZ', 'SOCS3', 'PAK1', 'RPS6KA2', 'FLNA', 'HRAS', 'PPIA', 'YWHAG']",0.49915596394807354,0,0,15
88,Cardiac Progenitor Differentiation WP2406,0.09383255574788403,2.464268112370626,5.831058173936707,"['MESP1', 'SOX1', 'NOTCH1', 'NRG1', 'THY1']",0.49915596394807354,0,0,5
89,Nucleotide metabolism WP404,0.09383255574788403,2.464268112370626,5.831058173936707,"['DHFR', 'NME2', 'HPRT1', 'SAT1', 'OAZ1']",0.49915596394807354,0,0,5
90,SREBF and miR33 in cholesterol and lipid homeostasis WP2011,0.09383255574788403,2.464268112370626,5.831058173936707,"['SREBF1', 'HMGCS1', 'SCD', 'FASN', 'HMGCR']",0.49915596394807354,0,0,5
91,Endochondral Ossification with Skeletal Dysplasias WP4808,0.09512518376550638,1.7613636363636365,4.143716332959026,"['HMGCS1', 'ADAMTS1', 'SPP1', 'COL10A1', 'SLC38A2', 'BMP7', 'FGFR3', 'IGF1R', 'DDR2', 'VEGFA']",0.49915596394807354,0,0,10
92,Endochondral Ossification WP474,0.09512518376550638,1.7613636363636365,4.143716332959026,"['HMGCS1', 'ADAMTS1', 'SPP1', 'COL10A1', 'SLC38A2', 'BMP7', 'FGFR3', 'IGF1R', 'DDR2', 'VEGFA']",0.49915596394807354,0,0,10
93,Apoptosis-related network due to altered Notch3 in ovarian cancer WP2864,0.09746706248301093,1.6954708353929808,3.9474643381257453,"['BEX3', 'SOCS3', 'NQO1', 'CDKN1A', 'HSPB1', 'TNFRSF10B', 'NRG1', 'RNF7', 'APOE', 'YBX3', 'ETS1']",0.49915596394807354,0,0,11
94,Glucocorticoid Receptor Pathway WP2880,0.09746706248301093,1.6954708353929808,3.9474643381257453,"['AKAP13', 'HSP90AA1', 'GADD45B', 'DNER', 'ENC1', 'CCL2', 'SPINK13', 'PMP2', 'SPRY1', 'ANGPTL4', 'SLC19A2']",0.49915596394807354,0,0,11
95,Senescence and Autophagy in Cancer WP615,0.09882767742423695,1.4981408031730292,3.467263482930637,"['GABARAPL2', 'GABARAPL1', 'CDKN1A', 'CEBPB', 'SMAD3', 'FN1', 'CXCL14', 'GABARAP', 'IGF1R', 'MAP1LC3A', 'IFI16', 'FKBP8', 'IRF7', 'COL10A1', 'SLC39A1', 'HRAS', 'CD44']",0.49915596394807354,0,0,17
96,Cholesterol Biosynthesis with Skeletal Dysplasias WP4804,0.09885554196904058,3.694977843426883,8.550532215308712,"['CYP51A1', 'DHCR24', 'DHCR7']",0.49915596394807354,0,0,3
97,Development of pulmonary dendritic cells and macrophage subsets WP3892,0.09885554196904058,3.694977843426883,8.550532215308712,"['CSF1', 'ID2', 'STAT3']",0.49915596394807354,0,0,3
98,"GPCRs, Class B Secretin-like WP334",0.09885554196904058,3.694977843426883,8.550532215308712,"['CALCRL', 'ADGRG2', 'ADGRL2']",0.49915596394807354,0,0,3
99,MicroRNA for Targeting Cancer Growth and Vascularization in Glioblastoma WP3593,0.09885554196904058,3.694977843426883,8.550532215308712,"['HEY1', 'HES1', 'VEGFA']",0.49915596394807354,0,0,3
100,Osteoclast Signaling WP12,0.09885554196904058,3.694977843426883,8.550532215308712,"['ATP6V1G1', 'SPP1', 'TNFRSF11B']",0.49915596394807354,0,0,3
101,Transcriptional cascade regulating adipogenesis WP4211,0.09885554196904058,3.694977843426883,8.550532215308712,"['SREBF1', 'CEBPB', 'CEBPD']",0.49915596394807354,0,0,3
102,DNA damage response WP707,0.09893486069549047,1.6442466205077482,3.803625213933709,"['CDKN1A', 'CCND3', 'CCND2', 'GADD45B', 'CDK5', 'GADD45A', 'SESN1', 'TNFRSF10B', 'FAS', 'CYCS', 'BAX', 'PML']",0.49915596394807354,0,0,12
103,Deregulation of Rab and Rab Effector Genes in Bladder Cancer WP2291,0.09928961308189528,2.8157635467980295,6.503609371111436,"['RPH3A', 'RPH3AL', 'SYTL4', 'TBC1D10A']",0.49915596394807354,0,0,4
104,Fatty acid transporters WP5061,0.09928961308189528,2.8157635467980295,6.503609371111436,"['FABP3', 'FABP5', 'ACSL6', 'DBI']",0.49915596394807354,0,0,4
105,GDNF/RET signaling axis WP4830,0.09928961308189528,2.8157635467980295,6.503609371111436,"['ROBO2', 'IFT27', 'SPRY1', 'SLIT2']",0.49915596394807354,0,0,4
106,Hypertrophy Model WP516,0.09928961308189528,2.8157635467980295,6.503609371111436,"['WDR1', 'IL1R1', 'IL18', 'VEGFA']",0.49915596394807354,0,0,4
107,Kynurenine Pathway and links to Cellular Senescence WP5044,0.09928961308189528,2.8157635467980295,6.503609371111436,"['CDKN1A', 'AADAT', 'HAAO', 'AHR']",0.49915596394807354,0,0,4
108,Leptin Insulin Overlap WP3935,0.09928961308189528,2.8157635467980295,6.503609371111436,"['SOCS3', 'IRS1', 'STAT3', 'IRS2']",0.49915596394807354,0,0,4
109,TP53 network WP1742,0.09928961308189528,2.8157635467980295,6.503609371111436,"['CDKN1A', 'SUMO1', 'GADD45A', 'BAX']",0.49915596394807354,0,0,4
110,Type II diabetes mellitus WP1584,0.09928961308189528,2.8157635467980295,6.503609371111436,"['SURF1', 'IRS1', 'CACNA1A', 'PRKCZ']",0.49915596394807354,0,0,4
111,Nephrotic syndrome WP4758,0.10681634313819754,1.775111111111111,3.970292216918988,"['CUBN', 'MYO1E', 'ANLN', 'PODXL', 'ITGA3', 'PLCE1', 'MYH9', 'COQ8B', 'SYNPO']",0.5321570968957049,0,0,9
112,Focal Adhesion-PI3K-Akt-mTOR-signaling pathway WP3932,0.12041630276744061,1.2594328959654038,2.665967995269068,"['ITGB1', 'LAMA5', 'CDKN1A', 'CRTC2', 'CSF1', 'CAB39L', 'IRS1', 'LAMA3', 'PIK3CD', 'IRS2', 'SLC2A3', 'PIK3C2A', 'IGF1R', 'GNG3', 'GNG2', 'FGF9', 'PPP2R1A', 'SPP1', 'TNR', 'HRAS', 'EIF4B', 'IFNAR2', 'SREBF1', 'HSP90AA1', 'ITGA3', 'EGF', 'HGF', 'RPS6', 'FN1', 'LAMB1', 'OSMR', 'VEGFA', 'EFNA1', 'KITLG', 'COL4A1', 'CDC37', 'FGFR3', 'FGF12', 'EPHA2']",0.5897615761044568,0,0,39
113,Hippo-Merlin Signaling Dysregulation WP4541,0.12157833576113576,1.46180670263921,3.080313945816108,"['ITGB1', 'PPP1R14A', 'ITGA3', 'CDH8', 'IGF1R', 'PAK1', 'PRKAR1A', 'PRKAR2B', 'CDH12', 'PAK3', 'FGFR3', 'HRAS', 'CDH18', 'CD44', 'EPHA2', 'TEAD3']",0.5897615761044568,0,0,16
114,Small cell lung cancer WP4658,0.12157833576113576,1.46180670263921,3.080313945816108,"['ITGB1', 'LAMA5', 'CDKN1A', 'GADD45B', 'ITGA3', 'GADD45A', 'LAMA3', 'FN1', 'PIK3CD', 'LAMB1', 'COL4A1', 'TRAF6', 'CYCS', 'BAX', 'RXRG', 'SKP1']",0.5897615761044568,0,0,16
115,Interferon type I signaling pathways WP585,0.12575766134697017,1.595417405716612,3.3079361302869947,"['IFNAR2', 'SOCS3', 'IRS1', 'RPS6', 'STAT3', 'PDCD4', 'PIK3CD', 'IRS2', 'GAB2', 'IRF9', 'EIF4B']",0.6047303193467348,0,0,11
116,Heart Development WP1591,0.12931689241047709,1.9714003944773175,4.03247852458915,"['SMAD1', 'NOTCH1', 'HEY1', 'NFATC2', 'NFATC1', 'VEGFA']",0.6112157393418276,0,0,6
117,Intracellular trafficking proteins involved in CMT neuropathy WP4856,0.12931689241047709,1.9714003944773175,4.03247852458915,"['RAB3A', 'HSPB8', 'HSPB1', 'NEFL', 'NDRG1', 'RAB11A']",0.6112157393418276,0,0,6
118,Blood Clotting Cascade WP272,0.13500269197218265,4.925196850393701,9.862512444173214,"['F3', 'KLKB1']",0.6221374055051417,0,0,2
119,Cells and molecules involved in local acute inflammatory response  WP4493,0.13500269197218265,4.925196850393701,9.862512444173214,"['ITGB1', 'ICAM1']",0.6221374055051417,0,0,2
120,Robo4 and VEGF Signaling Pathways Crosstalk WP3943,0.13500269197218265,4.925196850393701,9.862512444173214,"['SLIT2', 'VEGFA']",0.6221374055051417,0,0,2
121,Peptide GPCRs WP24,0.13896167499315776,2.9556868537666174,5.833216785507841,"['EDNRA', 'TAC4', 'NTSR2']",0.6350893080265805,0,0,3
122,Association Between Physico-Chemical Features and Toxicity Associated Pathways WP3680,0.1405353967743812,1.5173095944609298,2.9774103774285723,"['CDKN1A', 'PAK1', 'DAAM1', 'SHC1', 'FZD4', 'TMSB4X', 'FN1', 'NEFL', 'NEFM', 'PFN1', 'PFN2', 'SOD1']",0.6370170034117443,0,0,12
123,Ovarian infertility WP34,0.145484909662747,2.053146048956793,3.957814553197466,"['CEBPB', 'CCND2', 'SMAD3', 'INHA', 'SYNE2']",0.6540906914105618,0,0,5
124,Vitamin A and carotenoid metabolism WP716,0.15378252087639538,1.8480029585798816,3.459860479365664,"['RBP2', 'RBP1', 'BCO2', 'BCO1', 'RXRG', 'RLBP1']",0.6858204358439246,0,0,6
125,IL17 signaling pathway WP2112,0.15804266472983572,1.72496299950666,3.182367423663014,"['CEBPB', 'CEBPD', 'TRAF6', 'STAT3', 'IL17RE', 'MAP3K14', 'IL17RB']",0.6883419658480043,0,0,7
126,Vitamin D-sensitive calcium signaling in depression WP4698,0.15804266472983572,1.72496299950666,3.182367423663014,"['GRIN2A', 'GRM5', 'GPX4', 'ITPR1', 'ATP2B4', 'ATP2B1', 'SLC8A1']",0.6883419658480043,0,0,7
127,Arrhythmogenic Right Ventricular Cardiomyopathy WP2118,0.15808215128878217,1.5064810237820618,2.7789158128573894,"['ITGB1', 'RYR2', 'ACTN2', 'ITGA3', 'ACTN1', 'CACNA1D', 'CACNG2', 'SLC8A1', 'ACTB', 'DSC2', 'ACTG1']",0.6883419658480043,0,0,11
128,Amyotrophic lateral sclerosis (ALS) WP2447,0.15988359758594248,1.6429746627179993,3.0120806361675694,"['CST3', 'PPP3CC', 'SLC1A2', 'NEFL', 'BAX', 'NEFM', 'SOD1', 'TNFRSF1A']",0.6907471051955171,0,0,8
129,IL-18 signaling pathway WP4754,0.1613606992181144,1.23425,2.251411534511519,"['CEBPB', 'NRN1', 'EPB41', 'CD81', 'HSPB8', 'PLOD3', 'HSPB1', 'TNFRSF11B', 'ICAM1', 'PTMS', 'SOCS3', 'TMSB4X', 'STMN1', 'NFKBIZ', 'SPP1', 'CCL2', 'RPS11', 'B2M', 'TICAM2', 'FN1', 'IL18', 'EEF2', 'VEGFA', 'TNFRSF1A', 'ACTA2', 'KITLG', 'TRAF6', 'FAS', 'CYCS', 'BAX', 'KIFC3', 'PTPN7', 'CDK5R2', 'ARF6']",0.6910305552752052,0,0,34
130,Phytochemical activity on NRF2 transcriptional activation WP3,0.16369801580660376,2.1896004378763,3.962589794817051,"['NQO1', 'CEBPB', 'MAF', 'GCLM']",0.6910305552752052,0,0,4
131,Regulation of apoptosis by parathyroid hormone-related protein WP3872,0.16369801580660376,2.1896004378763,3.962589794817051,"['GSK3A', 'BAX', 'BCL2L14', 'BCL2L2']",0.6910305552752052,0,0,4
132,Gastric acid production WP2596,0.16888051578322769,inf,inf,['CCK'],0.6994991799189711,0,0,1
133,Neural Crest Differentiation WP2064,0.1696047721443237,1.4244323492220572,2.5273481222565173,"['ITGB1', 'SMAD1', 'NOTCH1', 'TBX6', 'ETS1', 'BMP7', 'GFAP', 'RHOB', 'DCT', 'ZIC1', 'HES1', 'FGFR3', 'HES5']",0.6994991799189711,0,0,13
134,Genes controlling nephrogenesis WP4823,0.1750036433307986,1.8950221784130112,3.3029260372603564,"['ROBO2', 'ITGB1', 'ITGA3', 'SLIT2', 'VEGFA']",0.6994991799189711,0,0,5
135,Type I interferon induction and signaling during SARS-CoV-2 infection WP4868,0.1750036433307986,1.8950221784130112,3.3029260372603564,"['IFIH1', 'IFNAR2', 'TRAF6', 'IRF7', 'IRF9']",0.6994991799189711,0,0,5
136,Zinc homeostasis WP3529,0.1750036433307986,1.8950221784130112,3.3029260372603564,"['SLC39A11', 'SLC39A7', 'SLC30A10', 'SLC39A1', 'SLC39A14']",0.6994991799189711,0,0,5
137,Translation Factors WP107,0.1756664832991995,1.4656183618121335,2.548956647332368,"['EIF4A2', 'EEF1B2', 'EIF5A', 'EEF1A1', 'EIF1AX', 'EEF1A2', 'EIF4H', 'EEF2', 'GSPT2', 'EIF4B', 'EIF1']",0.6994991799189711,0,0,11
138,IL-4 signaling pathway WP395,0.178270949577019,1.493741765480896,2.5758840292338383,"['SOCS3', 'CEBPB', 'NFIL3', 'IRS1', 'SHC1', 'STAT3', 'PIK3CD', 'FLNA', 'IRS2', 'GAB2']",0.6994991799189711,0,0,10
139,IL-2 signaling pathway WP49,0.18172916128311303,1.5770977295162882,2.689326702220315,"['SOCS3', 'CCND2', 'SHC1', 'STAT3', 'RPS6', 'NMI', 'GAB2', 'HRAS']",0.6994991799189711,0,0,8
140,Allograft Rejection WP2328,0.18188404433762326,1.642657457654991,2.7997222323147337,"['TUBA1B', 'HLA-B', 'HLA-C', 'FAS', 'PRKCZ', 'HLA-E', 'VEGFA']",0.6994991799189711,0,0,7
141,Alpha 6 Beta 4 signaling pathway WP244,0.18188404433762326,1.642657457654991,2.7997222323147337,"['LAMA5', 'SHC1', 'IRS1', 'LAMA3', 'IRS2', 'LAMB1', 'HRAS']",0.6994991799189711,0,0,7
142,Prader-Willi and Angelman Syndrome WP3998,0.18188404433762326,1.642657457654991,2.7997222323147337,"['CCND2', 'SNRPN', 'NDN', 'GABRG3', 'PRKCZ', 'GABRD', 'GABRG2']",0.6994991799189711,0,0,7
143,The influence of laminopathies on Wnt signaling WP4844,0.18188404433762326,1.642657457654991,2.7997222323147337,"['SREBF1', 'CEBPB', 'CEBPD', 'SPP1', 'HMGA2', 'HES1', 'HES5']",0.6994991799189711,0,0,7
144,Dopamine metabolism WP2436,0.18341298569303946,2.4628261939931066,4.176989961416385,"['NQO1', 'MAOB', 'SOD1']",0.6994991799189711,0,0,3
145,Glutathione metabolism WP100,0.18341298569303946,2.4628261939931066,4.176989961416385,"['GPX4', 'OPLAH', 'GCLM']",0.6994991799189711,0,0,3
146,G Protein Signaling Pathways WP35,0.18812158621879357,1.3372528598545295,2.2341039427766796,"['ITPR1', 'ADCY2', 'AKAP5', 'PRKCZ', 'GNAI1', 'AKAP12', 'AKAP13', 'GNA14', 'AKAP10', 'GNG3', 'PPP3CC', 'PRKAR1A', 'PRKAR2B', 'PRKCQ', 'PDE8B', 'HRAS']",0.7125427204040605,0,0,16
147,Transcription factor regulation in adipogenesis WP3599,0.20028841018726712,1.9704433497536946,3.1684667985314467,"['CEBPB', 'CEBPD', 'IRS1', 'IRS2']",0.7391784671106147,0,0,4
148,miR-517 relationship with ARCN1 and USP1 WP3596,0.2005004883663512,3.2831364829396326,5.275798732000088,"['CDKN1A', 'ID2']",0.7391784671106147,0,0,2
149,PTF1A related regulatory pathway WP4147,0.2005004883663512,3.2831364829396326,5.275798732000088,"['NOTCH1', 'HES1']",0.7391784671106147,0,0,2
150,Role of Osx and miRNAs in tooth development WP3971,0.2005004883663512,3.2831364829396326,5.275798732000088,"['NOTCH1', 'BMP7']",0.7391784671106147,0,0,2
151,TNF-alpha signaling pathway WP231,0.20323522661993326,1.314833168153287,2.0950436245232598,"['HSP90AA1', 'OTUD7B', 'PYGL', 'KSR2', 'TXN', 'PRKCZ', 'TNFRSF1A', 'RFK', 'CDC37', 'CCL2', 'BAX', 'TAB2', 'RFFL', 'HRAS', 'MAP3K14', 'SKP1']",0.7442985451710138,0,0,16
152,Signal transduction through IL1R WP4496,0.20806077720544125,1.6423405654174885,2.5783515841949383,"['IRAK2', 'IL1R1', 'TRAF6', 'TOLLIP', 'IL1RAP', 'MAP3K14']",0.7569579591750593,0,0,6
153,"Non-genomic actions of 1,25 dihydroxyvitamin D3 WP4341",0.21342045574220306,1.3901796012522656,2.1471200053705775,"['IFI27L2', 'CAMK2A', 'PLCG2', 'PLCE1', 'CCL2', 'PRKCQ', 'ETS1', 'HRAS', 'PRKCZ', 'RXRG', 'TNFRSF1A']",0.7709721536757166,0,0,11
154,Alzheimer's disease WP2059,0.21470110608690843,1.3272277227722773,2.041951029837499,"['ATP5MD', 'ITPR1', 'CACNA1D', 'TNFRSF1A', 'GRIN2A', 'PPP3CC', 'CDK5', 'FAS', 'CYCS', 'CALM3', 'APOE', 'GAPDH', 'SNCA', 'CDK5R1']",0.7709721536757166,0,0,14
155,Metapathway biotransformation Phase I and II WP702,0.21889027392690386,1.2931485483111018,1.9645314985012812,"['HS3ST3B1', 'CHST9', 'CHST6', 'CHST7', 'GPX4', 'GSTP1', 'EPHX1', 'CYP51A1', 'MGST1', 'KCNAB1', 'KCNAB2', 'CYP3A5', 'HS6ST3', 'CYP3A7', 'CYP39A1', 'SULT4A1']",0.7809440095585667,0,0,16
156,Fragile X Syndrome  WP4549,0.22371837405871886,1.2328528827037772,1.8460335636769303,"['GABRB2', 'GABRA1', 'KCNC1', 'SHC1', 'GAD1', 'CAMK2A', 'ITPR1', 'CLTB', 'CLTA', 'AKAP5', 'SLC6A1', 'GABRG2', 'GRM1', 'EEF1A1', 'GRIN2A', 'GRM5', 'PRKAR1A', 'MAP1B', 'CAMK4', 'AP2S1', 'GABRD', 'SHANK1']",0.7923453542320633,0,0,22
157,Osteoblast differentiation WP4787,0.22533079898256786,1.2972810927765177,1.933189783656583,"['HES6', 'SMAD1', 'NOTCH1', 'WNT2B', 'FZD4', 'WNT7B', 'SMAD9', 'PIK3CD', 'WNT7A', 'PIK3C2A', 'PRKCZ', 'FGF9', 'HEY1', 'PRKCQ', 'FGFR3']",0.7923453542320633,0,0,15
158,MECP2 and Associated Rett Syndrome WP3584,0.22699750610478703,1.344213649851632,1.9932218406269278,"['MPP1', 'RBFOX1', 'CEBPD', 'BCL6', 'GAD1', 'RPS6', 'CAMK2A', 'NREP', 'GRIA3', 'IGF1R', 'FKBP5', 'GRIA4']",0.7923453542320633,0,0,12
159,Eicosanoid Synthesis WP167,0.2309198880265389,2.1107828655834564,3.093741588987462,"['PNPLA3', 'ALOX12', 'PLA2G5']",0.7923453542320633,0,0,3
160,Galanin receptor pathway WP4970,0.2309198880265389,2.1107828655834564,3.093741588987462,"['CDKN1A', 'VAMP2', 'VEGFA']",0.7923453542320633,0,0,3
161,Matrix Metalloproteinases WP129,0.2309198880265389,2.1107828655834564,3.093741588987462,"['MMP15', 'MMP17', 'TIMP2']",0.7923453542320633,0,0,3
162,Primary focal segmental glomerulosclerosis (FSGS) WP2572,0.23346384709207785,1.3552891744933266,1.9715771702735836,"['ITGB1', 'LAMA5', 'MYO1E', 'CDKN1A', 'NOTCH1', 'ITGA3', 'PODXL', 'PLCE1', 'MYH9', 'SYNPO', 'VCL']",0.7923453542320633,0,0,11
163,CAMKK2  Pathway WP4874,0.23354844980077094,1.4995173848694794,2.1808466954989725,"['CHRM3', 'FIS1', 'MAP1LC3A', 'MAF', 'CAMK4', 'NFATC2', 'ICAM1']",0.7923453542320633,0,0,7
164,MFAP5 effect on permeability and motility of endothelial cells via cytoskeleton rearrangement WP4560,0.2389996320573306,1.7911330049261083,2.5636366094657093,"['ACTN1', 'ITPR1', 'PRKCQ', 'VCL']",0.7939775736028358,0,0,4
165,Statin inhibition of cholesterol production WP430,0.2389996320573306,1.7911330049261083,2.5636366094657093,"['SQLE', 'APOC1', 'HMGCR', 'APOE']",0.7939775736028358,0,0,4
166,Cell migration and invasion through p75NTR WP4561,0.23977261264317107,1.6420239855429604,2.3449157547989783,"['EFNA1', 'ARF1', 'PAK1', 'PARD3', 'STAT3']",0.7939775736028358,0,0,5
167,Oxidative Stress WP408,0.23977261264317107,1.6420239855429604,2.3449157547989783,"['NQO1', 'MGST1', 'SOD2', 'JUNB', 'SOD1']",0.7939775736028358,0,0,5
168,Melanoma WP4685,0.24646086777825377,1.3142103527860205,1.8406200030796303,"['GRM3', 'CDKN1A', 'GRIN2A', 'PAK1', 'GADD45B', 'GADD45A', 'PIK3CD', 'BAX', 'CALM3', 'ETS1', 'HRAS', 'VCL']",0.8112670231034186,0,0,12
169,Oxidative Damage WP3941,0.26792182499090206,1.477810650887574,1.9463653532243794,"['CDKN1A', 'C1S', 'C1R', 'GADD45A', 'TRAF6', 'CYCS']",0.8423669857808722,0,0,6
170,BMP2-WNT4-FOXO1 pathway in primary endometrial stromal cell differentiation WP3876,0.26855395745936483,2.4621062992125986,3.23693958759409,"['SMAD1', 'SMAD9']",0.8423669857808722,0,0,2
171,Complement Activation WP545,0.26855395745936483,2.4621062992125986,3.23693958759409,"['C1S', 'C1R']",0.8423669857808722,0,0,2
172,Insulin signaling in adipocytes (diabetic condition) WP3635,0.26855395745936483,2.4621062992125986,3.23693958759409,"['IRS1', 'RPS6']",0.8423669857808722,0,0,2
173,Insulin signaling in adipocytes (normal condition) WP3634,0.26855395745936483,2.4621062992125986,3.23693958759409,"['IRS1', 'RPS6']",0.8423669857808722,0,0,2
174,Monoamine GPCRs WP58,0.26855395745936483,2.4621062992125986,3.23693958759409,"['CHRM3', 'CHRM5']",0.8423669857808722,0,0,2
175,Peroxiredoxin 2 induced ovarian failure WP4873,0.26855395745936483,2.4621062992125986,3.23693958759409,"['PRDX2', 'BAX']",0.8423669857808722,0,0,2
176,Tryptophan metabolism WP465,0.2742900235005176,1.5392434696895023,1.9911180244402849,"['WARS', 'MAOB', 'AADAT', 'HAAO', 'DHCR24']",0.8423669857808722,0,0,5
177,Oncostatin M Signaling Pathway WP2374,0.27552265768831463,1.2904926676552975,1.6635552717906008,"['SOCS3', 'CEBPB', 'IRS1', 'SHC1', 'RPS6', 'STAT3', 'CCL2', 'OSMR', 'JUNB', 'HRAS', 'VEGFA']",0.8423669857808722,0,0,11
178,Apoptosis Modulation by HSP70 WP384,0.2792225879471678,1.6417077175697865,2.094402068596021,"['FAS', 'CYCS', 'TNFRSF1A', 'HSPA1A']",0.8423669857808722,0,0,4
179,Photodynamic therapy-induced NFE2L2 (NRF2) survival signaling WP3612,0.2792225879471678,1.6417077175697865,2.094402068596021,"['NQO1', 'GSTP1', 'EPHX1', 'GCLM']",0.8423669857808722,0,0,4
180,TGF-beta Receptor Signaling WP560,0.279856369845521,1.3590223644347619,1.7306861321366882,"['FKBP1A', 'SMAD1', 'SMAD3', 'EGF', 'STAT3', 'SPP1', 'SMAD9', 'HRAS']",0.8423669857808722,0,0,8
181,Cancer immunotherapy by PD-1 blockade WP4585,0.28028123939182725,1.8467503692762186,2.348995838003836,"['STAT3', 'NFATC2', 'NFATC1']",0.8423669857808722,0,0,3
182,Glycolysis in senescence WP5049,0.28028123939182725,1.8467503692762186,2.348995838003836,"['LDHA', 'PGK1', 'GAPDH']",0.8423669857808722,0,0,3
183,Imatinib and Chronic Myeloid Leukemia WP3640,0.28028123939182725,1.8467503692762186,2.348995838003836,"['GADD45A', 'PIM1', 'GAB2']",0.8423669857808722,0,0,3
184,Tryptophan catabolism leading to NAD+ production WP4210,0.28028123939182725,1.8467503692762186,2.348995838003836,"['AADAT', 'HAAO', 'NAMPT']",0.8423669857808722,0,0,3
185,Regulation of Actin Cytoskeleton WP51,0.28881164376850166,1.1762295081967213,1.4608541774189896,"['CHRM3', 'EGF', 'ACTN1', 'CHRM5', 'FN1', 'BRK1', 'PIK3CD', 'PIK3C2A', 'ACTB', 'ACTG1', 'PAK1', 'MRAS', 'FGF9', 'TMSB4X', 'CFL1', 'PIP4K2A', 'PFN1', 'PAK3', 'FGFR3', 'FGF12', 'VCL']",0.860243444980468,0,0,21
186,Photodynamic therapy-induced AP-1 survival signaling. WP3611,0.28934047154858417,1.3792797237296497,1.710515379751764,"['CDKN1A', 'HSP90AA1', 'TRAF6', 'FAS', 'BAX', 'JUNB', 'TNFRSF1A']",0.860243444980468,0,0,7
187,Neural Crest Cell Migration during Development WP4564,0.2993158674272483,1.4072978303747534,1.6975612411484517,"['ARF1', 'PAK1', 'STAT3', 'PIK3CD', 'PAK3', 'EPHB1']",0.8851426453864615,0,0,6
188,7q11.23 copy number variation syndrome WP4932,0.30405631019358936,1.1945820944829864,1.4222005905536623,"['SNAP25', 'ATP5MC3', 'NRG1', 'HSPA2', 'ATP5F1E', 'USF1', 'ATP5MC1', 'CLIP2', 'ABHD11', 'ATP5F1B', 'CFL1', 'EIF4H', 'ATP5PO', 'FAS', 'GAPDH', 'VAMP2']",0.8857571940440289,0,0,16
189,One-carbon metabolism and related pathways WP3940,0.3063831984211428,1.313589996709444,1.5538701424195254,"['BHMT', 'AHCYL1', 'GPX4', 'GAD1', 'GAD2', 'SOD2', 'GCLM', 'SOD1']",0.8857571940440289,0,0,8
190,EGFR Tyrosine Kinase Inhibitor Resistance WP4806,0.3064508050168222,1.2101962827861734,1.4312967742599703,"['SHC1', 'EGF', 'HGF', 'RPS6', 'STAT3', 'PIK3CD', 'NRG1', 'IGF1R', 'VEGFA', 'MRAS', 'PLCG2', 'BAX', 'HRAS', 'FGFR3']",0.8857571940440289,0,0,14
191,Pyrimidine metabolism WP4022,0.3064508050168222,1.2101962827861734,1.4312967742599703,"['ENTPD3', 'NME2', 'NME3', 'NME1', 'NT5C', 'POLE4', 'POLD4', 'POLE3', 'POLR2E', 'POLR2G', 'ENPP3', 'POLR2I', 'POLR2K', 'POLR2L']",0.8857571940440289,0,0,14
192,Aflatoxin B1 metabolism WP699,0.3092520931885667,4.923266109198229,5.777937716600335,['EPHX1'],0.8857571940440289,0,0,1
193,Control of immune tolerance by vasoactive intestinal peptide WP4484,0.3092520931885667,4.923266109198229,5.777937716600335,['FAS'],0.8857571940440289,0,0,1
194,Ras signaling WP4223,0.3107357968255725,1.1409306269933448,1.3335336997883795,"['SHC1', 'RASGRF1', 'PIK3CD', 'PLA2G5', 'ETS1', 'ETS2', 'IGF1R', 'GRIN2A', 'GNG3', 'PAK1', 'GNG2', 'PLCG2', 'PLCE1', 'PAK3', 'RALGDS', 'HRAS', 'KSR2', 'GAB2', 'MRAS', 'RASA4', 'CALM3', 'RAPGEF5', 'FGFR3', 'EPHA2', 'ARF6']",0.8857571940440289,0,0,25
195,Epithelial to mesenchymal transition in colorectal cancer WP4239,0.3181498685247154,1.1670582706766917,1.336553320704811,"['NOTCH1', 'SMAD3', 'WNT2B', 'SHC1', 'FZD4', 'WNT7B', 'EIF5A2', 'FN1', 'PIK3CD', 'WNT7A', 'CLDN11', 'CLDN20', 'PAK1', 'COL4A1', 'MMP15', 'ID2', 'TRAF6', 'HRAS']",0.8901800094935416,0,0,18
196,Thyroid stimulating hormone (TSH) signaling pathway WP2032,0.31967908440684156,1.231586752347998,1.4045478986861826,"['CCND3', 'GNG2', 'APEX1', 'RPS6', 'STAT3', 'ADCY2', 'HRAS', 'RALGDS', 'GNAI1', 'IGF1R', 'MYL12B']",0.8901800094935416,0,0,11
197,Canonical and non-canonical Notch signaling WP3845,0.32037263694026547,1.5152709359605911,1.7247881608215956,"['NOTCH1', 'HEY1', 'DNER', 'HES1']",0.8901800094935416,0,0,4
198,Monoamine Transport WP727,0.32037263694026547,1.5152709359605911,1.7247881608215956,"['IL1R1', 'TNFRSF11B', 'AMPH', 'SLC6A1']",0.8901800094935416,0,0,4
199,Sterol regulatory element-binding proteins (SREBP) signaling WP1982,0.32948658379239304,1.2064434082238236,1.339417169658633,"['SREBF1', 'FDPS', 'SQLE', 'GSK3A', 'HMGCS1', 'MDH1', 'SCD', 'FASN', 'CYP51A1', 'DBI', 'HMGCR', 'SEC24D']",0.8901800094935416,0,0,12
200,Cysteine and methionine catabolism WP4504,0.3304288425787289,1.641391761037256,1.8176180561290673,"['BHMT', 'ETHE1', 'SQOR']",0.8901800094935416,0,0,3
201,Interactions between immune cells and microRNAs in tumor microenvironment WP4559,0.3304288425787289,1.641391761037256,1.8176180561290673,"['TRAF6', 'STAT3', 'CCL2']",0.8901800094935416,0,0,3
202,Bladder cancer WP2828,0.33134272295592193,1.3431952662721893,1.4836962077286795,"['CDKN1A', 'EGF', 'DAPK2', 'HRAS', 'FGFR3', 'VEGFA']",0.8901800094935416,0,0,6
203,IL-1 signaling pathway WP195,0.33219543664446405,1.2314723320158103,1.3571216936918447,"['IL1R1', 'IRAK2', 'TRAF6', 'TOLLIP', 'PELI1', 'CCL2', 'TAB2', 'IL1RAP', 'PRKCZ', 'MAP3K14']",0.8901800094935416,0,0,10
204,ApoE and miR-146 in inflammation and atherosclerosis WP3926,0.3364333128103982,1.969488188976378,2.145472452895925,"['TRAF6', 'APOE']",0.8901800094935416,0,0,2
205,"Cerebral organic acidurias, including diseases WP4519",0.3364333128103982,1.969488188976378,2.145472452895925,"['MDH2', 'ADHFE1']",0.8901800094935416,0,0,2
206,Glial Cell Differentiation WP2276,0.3364333128103982,1.969488188976378,2.145472452895925,"['GAP43', 'PLP1']",0.8901800094935416,0,0,2
207,Interleukin-1 Induced Activation of NF-kappa-B WP3656,0.3364333128103982,1.969488188976378,2.145472452895925,"['TRAF6', 'PRKCZ']",0.8901800094935416,0,0,2
208,Nanoparticle triggered regulated necrosis WP2513,0.3364333128103982,1.969488188976378,2.145472452895925,"['TNFRSF1A', 'FTL']",0.8901800094935416,0,0,2
209,Platelet-mediated interactions with vascular and circulating cells WP4462,0.3364333128103982,1.969488188976378,2.145472452895925,"['CCL2', 'ICAM1']",0.8901800094935416,0,0,2
210,Mechanoregulation and pathology of YAP/TAZ via Hippo and non-Hippo mechanisms WP4534,0.3477473440355179,1.2768550494253503,1.348715284275932,"['ITGB1', 'ACTA2', 'PAK1', 'PAK3', 'ACTB', 'ACTG1', 'TEAD3']",0.9157346726268637,0,0,7
211,PI3K-Akt signaling pathway WP4172,0.349416880474606,1.0917484058484939,1.1479620614861874,"['ITGB1', 'LAMA5', 'CDKN1A', 'CSF1', 'IRS1', 'LAMA3', 'PIK3CD', 'IGF1R', 'CCND3', 'GNG3', 'CCND2', 'GNG2', 'FGF9', 'PPP2R1A', 'SPP1', 'TNR', 'HRAS', 'EIF4B', 'IFNAR2', 'HSP90AA1', 'ITGA3', 'EGF', 'HGF', 'RPS6', 'FN1', 'LAMB1', 'OSMR', 'VEGFA', 'EFNA1', 'KITLG', 'COL4A1', 'CDC37', 'FGFR3', 'FGF12', 'EPHA2']",0.9157703075945836,0,0,35
212,Effect of progerin on genes involved in Hutchinson-Gilford progeria syndrome WP4320,0.3619066258237991,1.4068965517241379,1.4299260978546668,"['SREBF1', 'H3F3B', 'CBX3', 'CHD3']",0.9352073087876679,0,0,4
213,miRNA regulation of p53 pathway in prostate cancer WP3982,0.3619066258237991,1.4068965517241379,1.4299260978546668,"['SHISA5', 'TNFRSF10B', 'BAX', 'CYS1']",0.9352073087876679,0,0,4
214,Urea cycle and associated pathways WP4595,0.3619066258237991,1.4068965517241379,1.4299260978546668,"['OAT', 'MDH1', 'MDH2', 'GLS2']",0.9352073087876679,0,0,4
215,Development of ureteric collection system WP5053,0.36375153606620775,1.2846668381785438,1.2991633240725347,"['ROBO2', 'ITGB1', 'SMAD1', 'FRAS1', 'SPRY1', 'SLIT2']",0.9356027881144785,0,0,6
216,DNA damage response (only ATM dependent) WP710,0.372280117114296,1.136701337295691,1.1231844864557738,"['CDKN1A', 'SMAD3', 'WNT2B', 'IRS1', 'SHC1', 'WNT7B', 'PIK3CD', 'WNT7A', 'PIK3C2A', 'SOD2', 'CCND3', 'CCND2', 'BCL6', 'BAX', 'HRAS']",0.9491227056061073,0,0,15
217,Canonical and non-canonical TGF-B signaling WP3874,0.3804480775142907,1.4771048744460857,1.4274823774907717,"['SMAD3', 'LOXL1', 'LOXL2']",0.9491227056061073,0,0,3
218,Simplified Interaction Map Between LOXL4 and Oxidative Stress Pathway WP3670,0.3804480775142907,1.4771048744460857,1.4274823774907717,"['NQO1', 'CDC37', 'FN1']",0.9491227056061073,0,0,3
219,Neovascularisation processes WP4331,0.38197370989017443,1.295815932141838,1.2470977819971398,"['SMAD1', 'KITLG', 'NOTCH1', 'SMAD3', 'SMAD9']",0.9491227056061073,0,0,5
220,Photodynamic therapy-induced HIF-1 survival signaling WP3614,0.38197370989017443,1.295815932141838,1.2470977819971398,"['LDHA', 'PGK1', 'BAX', 'SLC2A3', 'VEGFA']",0.9491227056061073,0,0,5
221,Proteasome Degradation WP183,0.3883727342271725,1.1526277594892775,1.0901435150363266,"['PSMD10', 'PSMB6', 'UBB', 'UBE2B', 'H2AFZ', 'NEDD4', 'HLA-B', 'HLA-C', 'PSMB10', 'HLA-E', 'PSMB9']",0.9491227056061073,0,0,11
222,TGF-beta receptor signaling in skeletal dysplasias WP4816,0.38838507600377237,1.1938137545245147,1.129058870170033,"['FKBP1A', 'SMAD1', 'SMAD3', 'EGF', 'STAT3', 'SPP1', 'SMAD9', 'HRAS']",0.9491227056061073,0,0,8
223,Factors and pathways affecting insulin-like growth factor (IGF1)-Akt signaling WP3850,0.3963022985885483,1.231015779092702,1.1394010965358878,"['ITGB1', 'MAP1LC3A', 'SMAD3', 'IRS1', 'IGF1R', 'TNFRSF1A']",0.9491227056061073,0,0,6
224,Neural Crest Cell Migration in Cancer WP4565,0.3963022985885483,1.231015779092702,1.1394010965358878,"['ARF1', 'PAK1', 'STAT3', 'PIK3CD', 'PAK3', 'EPHB1']",0.9491227056061073,0,0,6
225,Type 2 papillary renal cell carcinoma WP4241,0.3963022985885483,1.231015779092702,1.1394010965358878,"['CDKN1A', 'EGLN3', 'COL21A1', 'ELOB', 'ELOC', 'VEGFA']",0.9491227056061073,0,0,6
226,Autosomal recessive Osteopetrosis pathways WP4788,0.4022571716988987,1.6410761154855642,1.4944683887384378,"['TRAF6', 'SNX10']",0.9491227056061073,0,0,2
227,Hijack of ubiquitination by SARS-CoV-2 WP4860,0.4022571716988987,1.6410761154855642,1.4944683887384378,"['ELOB', 'ELOC']",0.9491227056061073,0,0,2
228,Mammary gland development pathway - Puberty (Stage 2 of 4) WP2814,0.4022571716988987,1.6410761154855642,1.4944683887384378,"['EGF', 'FN1']",0.9491227056061073,0,0,2
229,RAS and bradykinin pathways in COVID-19 WP4969,0.4022571716988987,1.6410761154855642,1.4944683887384378,"['SERPING1', 'KLKB1']",0.9491227056061073,0,0,2
230,TFs regulate miRNAs related to cardiac hypertrophy WP1559,0.4022571716988987,1.6410761154855642,1.4944683887384378,"['STAT3', 'RASGRF1']",0.9491227056061073,0,0,2
231,Thiamine metabolic pathways WP4297,0.4022571716988987,1.6410761154855642,1.4944683887384378,"['SLC19A3', 'SLC19A2']",0.9491227056061073,0,0,2
232,7-oxo-C and 7beta-HC pathways WP5064,0.4033342419845122,1.3129720853858784,1.1921650986794499,"['HSD11B1', 'DBP', 'DHCR7', 'ACOT6']",0.9491227056061073,0,0,4
233,FBXL10 enhancement of MAP/ERK signaling in diffuse large B-cell lymphoma WP4553,0.4033342419845122,1.3129720853858784,1.1921650986794499,"['H3F3B', 'BCL6', 'H2AFJ', 'H2AFZ']",0.9491227056061073,0,0,4
234,Mammary gland development pathway - Pregnancy and lactation (Stage 3 of 4) WP2817,0.4033342419845122,1.3129720853858784,1.1921650986794499,"['TTC9', 'CEBPB', 'TPM3', 'ATP2C2']",0.9491227056061073,0,0,4
235,TYROBP causal network in microglia WP3945,0.4033342419845122,1.3129720853858784,1.1921650986794499,"['MAF', 'IL18', 'SPP1', 'IL13RA1']",0.9491227056061073,0,0,4
236,T-cell receptor (TCR) signaling pathway WP69,0.41158604772395063,1.128501400560224,1.0018126433474401,"['PAK1', 'SHC1', 'TRAF6', 'ITPR1', 'NFATC2', 'FAS', 'PRKCQ', 'NFATC1', 'GAB2', 'HRAS', 'MAP3K14']",0.9578997202309892,0,0,11
237,Benzo(a)pyrene metabolism WP696,0.4259253427929424,2.4613871126414164,2.1007722397704804,['EPHX1'],0.9578997202309892,0,0,1
238,Composition of Lipid Particles WP3601,0.4259253427929424,2.4613871126414164,2.1007722397704804,['APOE'],0.9578997202309892,0,0,1
239,COVID-19 adverse outcome pathway WP4891,0.4259253427929424,2.4613871126414164,2.1007722397704804,['CCL2'],0.9578997202309892,0,0,1
240,Hypothetical Craniofacial Development Pathway WP3655,0.4259253427929424,2.4613871126414164,2.1007722397704804,['ARHGAP29'],0.9578997202309892,0,0,1
241,Macrophage markers WP4146,0.4259253427929424,2.4613871126414164,2.1007722397704804,['F3'],0.9578997202309892,0,0,1
242,Metabolism of alpha-linolenic acid WP4586,0.4259253427929424,2.4613871126414164,2.1007722397704804,['ALOX12'],0.9578997202309892,0,0,1
243,Steroid Biosynthesis WP496,0.4259253427929424,2.4613871126414164,2.1007722397704804,['HSD17B7'],0.9578997202309892,0,0,1
244,Tamoxifen metabolism WP691,0.4259253427929424,2.4613871126414164,2.1007722397704804,['CYP3A5'],0.9578997202309892,0,0,1
245,ERK Pathway in Huntington's Disease WP3853,0.4295825146786353,1.3426883308714919,1.1344930090933663,"['EGF', 'HRAS', 'GRM1']",0.9578997202309892,0,0,3
246,NAD+ metabolism WP3644,0.4295825146786353,1.3426883308714919,1.1344930090933663,"['NT5E', 'NAMPT', 'CD38']",0.9578997202309892,0,0,3
247,Nanomaterial induced apoptosis WP2507,0.4295825146786353,1.3426883308714919,1.1344930090933663,"['BAX', 'FAS', 'CYCS']",0.9578997202309892,0,0,3
248,SARS coronavirus and innate immunity WP4912,0.4295825146786353,1.3426883308714919,1.1344930090933663,"['IFIH1', 'IFNAR2', 'IRF9']",0.9578997202309892,0,0,3
249,Breast cancer pathway WP4262,0.44166657958898614,1.0678786574870913,0.8726704670765183,"['CDKN1A', 'NOTCH1', 'WNT2B', 'GADD45B', 'SHC1', 'GADD45A', 'EGF', 'WNT7B', 'PIK3CD', 'WNT7A', 'IGF1R', 'FGF9', 'HEY1', 'BAX', 'HES1', 'HRAS', 'HES5', 'SKP1']",0.9709732117826815,0,0,18
250,DNA Mismatch Repair WP531,0.44422463396205863,1.2307881773399014,0.9986921886653523,"['POLE4', 'POLD4', 'RPA3', 'POLE3']",0.9709732117826815,0,0,4
251,Fatty Acid Biosynthesis WP357,0.44422463396205863,1.2307881773399014,0.9986921886653523,"['ACSS2', 'SCD', 'FASN', 'ACSL6']",0.9709732117826815,0,0,4
252,Fibrin Complement Receptor 3 Signaling Pathway WP4136,0.44422463396205863,1.2307881773399014,0.9986921886653523,"['TICAM2', 'IRAK2', 'TRAF6', 'CCL2']",0.9709732117826815,0,0,4
253,Toll-like Receptor Signaling related to MyD88 WP3858,0.44422463396205863,1.2307881773399014,0.9986921886653523,"['TICAM2', 'TRAF6', 'TOLLIP', 'IRF7']",0.9709732117826815,0,0,4
254,Cell cycle WP179,0.4508820161593154,1.0703749165536103,0.8526066888021401,"['CDKN2D', 'ANAPC13', 'CDKN1A', 'SMAD3', 'GADD45B', 'GADD45A', 'YWHAB', 'CDC7', 'YWHAZ', 'ANAPC11', 'CCND3', 'CCND2', 'YWHAG', 'SKP1', 'YWHAH']",0.9769939915262172,0,0,15
255,Hepatitis C and Hepatocellular Carcinoma WP3646,0.46094555488542255,1.136094674556213,0.8798773152124078,"['CDKN1A', 'SMAD3', 'PODXL', 'STAT3', 'CD44', 'VEGFA']",0.9769939915262172,0,0,6
256,NO/cGMP/PKG mediated Neuroprotection WP4008,0.46094555488542255,1.136094674556213,0.8798773152124078,"['GUCY1A2', 'GRIN2A', 'ACTN2', 'CAMK2A', 'NEFL', 'CYCS']",0.9769939915262172,0,0,6
257,Pathways Regulating Hippo Signaling WP4540,0.4616305938228754,1.0741839762611276,0.8303337813956356,"['SMAD3', 'PRKAR1A', 'PRKAR2B', 'CDH12', 'PRKCQ', 'PRKCZ', 'FGFR3', 'CDH8', 'CDH18', 'IGF1R', 'EPHA2', 'TEAD3']",0.9769939915262172,0,0,12
258,Pancreatic adenocarcinoma pathway WP4263,0.46488862313162155,1.066716147121887,0.8170591503020517,"['CDKN1A', 'SMAD3', 'GADD45B', 'EGF', 'GADD45A', 'STAT3', 'PEBP1', 'PIK3CD', 'VEGFA', 'PAK1', 'BAX', 'PAK3', 'RALGDS']",0.9769939915262172,0,0,13
259,Glycogen Synthesis and Degradation WP500,0.46648059198184044,1.1116539618377708,0.8476793481413576,"['GSK3A', 'PPP2R1A', 'HKDC1', 'PYGM', 'CALM3', 'PYGL', 'GYG2']",0.9769939915262172,0,0,7
260,IL-3 signaling pathway WP286,0.46648059198184044,1.1116539618377708,0.8476793481413576,"['YWHAB', 'SHC1', 'STAT3', 'PIK3CD', 'ENPP3', 'GAB2', 'HRAS']",0.9769939915262172,0,0,7
261,MAPK Signaling Pathway WP382,0.47130350275681787,1.029767618002912,0.7746457932943287,"['RASGRF1', 'CACNA1B', 'CACNA1A', 'HSPB1', 'CACNA1D', 'PAK1', 'PPP3CC', 'FGF9', 'STMN1', 'FLNA', 'MAP3K6', 'CACNG2', 'HRAS', 'HSPA8', 'IL1R1', 'GADD45A', 'EGF', 'NFATC1', 'HSPA2', 'MAPK8IP2', 'MAPK8IP1', 'TNFRSF1A', 'MRAS', 'TRAF6', 'FAS', 'TAB2', 'PTPN7', 'FGFR3', 'FGF12', 'MAP3K14', 'HSPA1B', 'HSPA1A']",0.9769939915262172,0,0,32
262,EGF/EGFR signaling pathway WP437,0.47244256402628093,1.0365017020162346,0.7772095003341678,"['NDUFA13', 'SHC1', 'EGF', 'LIMK2', 'CAMK2A', 'STAT3', 'PEBP1', 'NEDD8', 'GAB2', 'PTPN12', 'PRKCZ', 'EPN1', 'PLSCR1', 'PAK1', 'RPS6KA2', 'NEDD4', 'CFL1', 'STMN1', 'AP2S1', 'PLCE1', 'RALGDS', 'HRAS', 'SH3GL2', 'ARF6']",0.9769939915262172,0,0,24
263,Notch Signaling Pathway Netpath WP61,0.4748256060066744,1.080650406504065,0.8048767303840938,"['HES6', 'CDKN1A', 'NUMBL', 'NOTCH1', 'HEY1', 'STAT3', 'HES1', 'HES5', 'SKP1']",0.9769939915262172,0,0,9
264,Pregnane X receptor pathway WP2876,0.47722821394888315,1.2306745445593303,0.9104043752621069,"['HSP90AA1', 'CYP3A5', 'CYP3A7']",0.9769939915262172,0,0,3
265,Purinergic signaling WP4900,0.47722821394888315,1.2306745445593303,0.9104043752621069,"['P2RY12', 'P2RY14', 'GNAI1']",0.9769939915262172,0,0,3
266,Sleep regulation WP3591,0.47722821394888315,1.2306745445593303,0.9104043752621069,"['CST3', 'GRIN2A', 'IL18']",0.9769939915262172,0,0,3
267,Non-small cell lung cancer WP4255,0.48102954738514403,1.0617991141093115,0.7770528161178799,"['CDKN1A', 'GADD45B', 'EGF', 'GADD45A', 'STAT3', 'PLCG2', 'PIK3CD', 'CYCS', 'BAX', 'HRAS', 'RXRG']",0.9769939915262172,0,0,11
268,Retinoblastoma gene in cancer WP2446,0.48102954738514403,1.0617991141093115,0.7770528161178799,"['BARD1', 'DHFR', 'ANLN', 'CDKN1A', 'CCND3', 'H2AFZ', 'RPA3', 'STMN1', 'RBP1', 'HMGB2', 'CDC7']",0.9769939915262172,0,0,11
269,EPO Receptor Signaling WP581,0.48420923029444096,1.158272964358157,0.8400237669784754,"['SHC1', 'IRS1', 'STAT3', 'IRS2']",0.9769939915262172,0,0,4
270,miRNAs involvement in the immune response in sepsis WP4329,0.48420923029444096,1.158272964358157,0.8400237669784754,"['TRAF6', 'IRF7', 'TAB2', 'ICAM1']",0.9769939915262172,0,0,4
271,NRF2-ARE regulation WP4357,0.48420923029444096,1.158272964358157,0.8400237669784754,"['NQO1', 'CEBPB', 'MAF', 'GCLM']",0.9769939915262172,0,0,4
272,SARS-CoV-2 mitochondrial interactions WP5038,0.48420923029444096,1.158272964358157,0.8400237669784754,"['IFIH1', 'NDUFB9', 'TRAF6', 'IRF7']",0.9769939915262172,0,0,4
273,Trans-sulfuration and one-carbon metabolism WP2525,0.48420923029444096,1.158272964358157,0.8400237669784754,"['DHFR', 'BHMT', 'AHCYL1', 'GCLM']",0.9769939915262172,0,0,4
274,Wnt signaling in kidney disease WP4150,0.48420923029444096,1.158272964358157,0.8400237669784754,"['WNT2B', 'FZD4', 'WNT7B', 'WNT7A']",0.9769939915262172,0,0,4
275,Lipid Metabolism Pathway WP3965,0.48899892750111135,1.118777723016264,0.8003679698682966,"['ACSS2', 'PRKAR2B', 'PRKAR1A', 'FASN', 'HILPDA']",0.9769939915262172,0,0,5
276,Fas ligand pathway and stress induction of heat shock proteins WP314,0.4926417214003998,1.09390751698444,0.7744570965429756,"['PAK1', 'HSPB1', 'FAS', 'CYCS', 'ACTB', 'ACTG1']",0.9769939915262172,0,0,6
277,Splicing factor NOVA regulated synaptic proteins WP4148,0.4955891614735292,1.0768068574247656,0.7559270272588734,"['EPB41', 'EPB41L3', 'GRIK2', 'NCDN', 'ATP2B1', 'PRKCZ', 'GABRG2']",0.9769939915262172,0,0,7
278,GABA metabolism (aka GHB) WP4157,0.5228994993863845,1.6407607804558124,1.063813496252482,['ADHFE1'],0.9769939915262172,0,0,1
279,"Gamma-glutamyl cycle for the biosynthesis and degradation of glutathione, including diseases WP4518",0.5228994993863845,1.6407607804558124,1.063813496252482,['OPLAH'],0.9769939915262172,0,0,1
280,Irinotecan pathway WP229,0.5228994993863845,1.6407607804558124,1.063813496252482,['CYP3A5'],0.9769939915262172,0,0,1
281,LncRNA-mediated mechanisms of therapeutic resistance WP3672,0.5228994993863845,1.6407607804558124,1.063813496252482,['CDKN1A'],0.9769939915262172,0,0,1
282,Osteoblast Signaling WP322,0.5228994993863845,1.6407607804558124,1.063813496252482,['TNFRSF11B'],0.9769939915262172,0,0,1
283,Somatic sex determination WP4814,0.5228994993863845,1.6407607804558124,1.063813496252482,['FGF9'],0.9769939915262172,0,0,1
284,Synthesis and Degradation of Ketone Bodies WP311,0.5228994993863845,1.6407607804558124,1.063813496252482,['BDH1'],0.9769939915262172,0,0,1
285,The alternative pathway of fetal androgen synthesis WP4524,0.5228994993863845,1.6407607804558124,1.063813496252482,['HSD17B6'],0.9769939915262172,0,0,1
286,Microglia Pathogen Phagocytosis Pathway WP3937,0.5229217954016333,1.1358936484490398,0.7364263832198705,"['PLCG2', 'PIK3CD', 'PIK3C2A']",0.9769939915262172,0,0,3
287,Proteoglycan biosynthesis WP4784,0.5229217954016333,1.1358936484490398,0.7364263832198705,"['XYLT1', 'B3GALT6', 'B4GALT7']",0.9769939915262172,0,0,3
288,Serotonin Receptor 2 and ELK-SRF/GATA4 signaling WP732,0.5229217954016333,1.1358936484490398,0.7364263832198705,"['RASGRF1', 'ITPR1', 'HRAS']",0.9769939915262172,0,0,3
289,Oxidation by Cytochrome P450 WP43,0.5229816163629908,1.0938149972632731,0.7090206882538134,"['CYP39A1', 'CYP51A1', 'CYP3A5', 'CYP3A7']",0.9769939915262172,0,0,4
290,Type I collagen synthesis in the context of Osteogenesis imperfecta WP4786,0.5229816163629908,1.0938149972632731,0.7090206882538134,"['P4HA2', 'ITPR1', 'P3H2', 'TNFRSF11B']",0.9769939915262172,0,0,4
291,Amplification and Expansion of Oncogenic Pathways as Metastatic Traits WP3678,0.5232500635482429,1.2305610236220472,0.7970292019761002,"['NOTCH1', 'VEGFA']",0.9769939915262172,0,0,2
292,miRNAs involved in DNA damage response WP1545,0.5232500635482429,1.2305610236220472,0.7970292019761002,"['CDKN1A', 'CCND3']",0.9769939915262172,0,0,2
293,Osteopontin Signaling WP1434,0.5232500635482429,1.2305610236220472,0.7970292019761002,"['SPP1', 'MAP3K14']",0.9769939915262172,0,0,2
294,Pathways of nucleic acid metabolism and innate immune sensing WP4705,0.5232500635482429,1.2305610236220472,0.7970292019761002,"['IFIH1', 'SAMHD1']",0.9769939915262172,0,0,2
295,Serotonin and anxiety WP3947,0.5232500635482429,1.2305610236220472,0.7970292019761002,"['GABRA1', 'GRM1']",0.9769939915262172,0,0,2
296,G13 Signaling Pathway WP524,0.5236905012814191,1.0547337278106508,0.6822591690858818,"['CFL1', 'ARHGDIG', 'PIK3CD', 'PIP4K2A', 'PAK3', 'PFN1']",0.9769939915262172,0,0,6
297,Structural Pathway of Interleukin 1 (IL-1) WP2637,0.5247146753766483,1.036213435860134,0.6682547075481988,"['IL1R1', 'IRAK2', 'TRAF6', 'TOLLIP', 'IRF7', 'TAB2', 'IL1RAP', 'MAP3K14']",0.9769939915262172,0,0,8
298,TGF-beta Signaling Pathway WP366,0.5477032088461613,0.995284911717496,0.5991831428459846,"['ITGB1', 'CDKN1A', 'SMAD3', 'SHC1', 'LIMK2', 'FN1', 'NEDD4L', 'ETS1', 'PML', 'PJA1', 'EID2', 'KLF6', 'PARD6A', 'SUMO1', 'STAMBPL1', 'TRAF6', 'JUNB', 'SKP1']",0.9966398380664583,0,0,18
299,MET in type 1 papillary renal cell carcinoma WP4205,0.5498691657179936,1.0066666666666666,0.6020620756301923,"['CDKN1A', 'PAK1', 'HGF', 'RPL11', 'STAT3', 'PIK3CD', 'PAK3', 'ETS1', 'HRAS']",0.9966398380664583,0,0,9
300,Regucalcin in proximal tubule epithelial kidney cells WP4838,0.560295227830059,1.0361420793362717,0.6002282388581622,"['ACTA2', 'BAX', 'PRKCQ', 'TNFRSF1A']",0.9966398380664583,0,0,4
301,Hepatitis B infection WP4666,0.5644599743559217,0.9841191066997519,0.5628037450921707,"['CDKN1A', 'TICAM2', 'SMAD3', 'ATP6AP1', 'SLC10A1', 'YWHAB', 'STAT3', 'NFATC2', 'PIK3CD', 'NFATC1', 'YWHAZ', 'IFIH1', 'TRAF6', 'IRF7', 'CYCS', 'FAS', 'BAX', 'TAB2', 'HRAS']",0.9966398380664583,0,0,19
302,Angiogenesis WP1539,0.5663251591386421,1.0546528803545052,0.5996617903253882,"['SMAD1', 'TIMP2', 'VEGFA']",0.9966398380664583,0,0,3
303,Hypothesized Pathways in Pathogenesis of Cardiovascular Disease WP3668,0.5663251591386421,1.0546528803545052,0.5996617903253882,"['SMAD3', 'SHC1', 'FLNA']",0.9966398380664583,0,0,3
304,Metabolism of Spingolipids in ER and Golgi apparatus WP4142,0.5663251591386421,1.0546528803545052,0.5996617903253882,"['UGT8', 'UGCG', 'GALNT16']",0.9966398380664583,0,0,3
305,One-carbon metabolism WP241,0.5663251591386421,1.0546528803545052,0.5996617903253882,"['DHFR', 'BHMT', 'GLRX']",0.9966398380664583,0,0,3
306,ESC Pluripotency Pathways WP3931,0.5680913424793,0.9841662543295399,0.556519502366921,"['SMAD1', 'WNT2B', 'FZD4', 'EGF', 'WNT7B', 'STAT3', 'SMAD9', 'PIK3CD', 'WNT7A', 'FGF9', 'FGFR3', 'FGF12', 'HRAS']",0.9966398380664583,0,0,13
307,Kit receptor signaling pathway WP304,0.5763362142370723,0.9842053307008884,0.5423602083448186,"['KITLG', 'SHC1', 'RPS6', 'STAT3', 'GAB2', 'JUNB', 'HRAS', 'SH2B2']",0.9966398380664583,0,0,8
308,Alanine and aspartate metabolism WP106,0.5772430989337333,1.0937226596675416,0.600991617531975,"['GAD1', 'GAD2']",0.9966398380664583,0,0,2
309,BMP Signaling Pathway in Eyelid Development WP3927,0.5772430989337333,1.0937226596675416,0.600991617531975,"['SMAD1', 'NOTCH1']",0.9966398380664583,0,0,2
310,Cell Differentiation - Index expanded WP2023,0.5772430989337333,1.0937226596675416,0.600991617531975,"['ID2', 'STAT3']",0.9966398380664583,0,0,2
311,GPR40 Pathway WP3958,0.5772430989337333,1.0937226596675416,0.600991617531975,"['PLCG2', 'PLCE1']",0.9966398380664583,0,0,2
312,MAPK and NFkB signaling pathways inhibited by Yersinia YopJ WP3849,0.5772430989337333,1.0937226596675416,0.600991617531975,"['TRAF6', 'MAP3K14']",0.9966398380664583,0,0,2
313,RalA downstream regulated genes WP2290,0.5772430989337333,1.0937226596675416,0.600991617531975,"['YBX3', 'HRAS']",0.9966398380664583,0,0,2
314,PPAR signaling pathway WP3942,0.5793599624662052,0.9842131228416379,0.5372143261029697,"['FABP3', 'FABP5', 'SCD', 'ACSL6', 'DBI', 'ANGPTL4', 'RXRG']",0.9966398380664583,0,0,7
315,Notch Signaling WP268,0.5832825823698029,0.9842209072978304,0.5305772575512604,"['LFNG', 'NUMBL', 'NOTCH1', 'DTX3L', 'HES1', 'HES5']",0.9966398380664583,0,0,6
316,SARS-CoV-2 innate immunity evasion and cell-specific immune response WP5039,0.5832825823698029,0.9842209072978304,0.5305772575512604,"['IFNAR2', 'SMAD3', 'TRAF6', 'CXCL17', 'IRF7', 'CCL2']",0.9966398380664583,0,0,6
317,Nanoparticle-mediated activation of receptor signaling WP2643,0.5959595074186679,0.9842364532019704,0.5094236179731624,"['ITGB1', 'FN1', 'PIK3CD', 'HRAS']",0.9966398380664583,0,0,4
318,Oxysterols derived from cholesterol WP4545,0.5959595074186679,0.9842364532019704,0.5094236179731624,"['CYP39A1', 'DBP', 'DHCR7', 'ACOT6']",0.9966398380664583,0,0,4
319,Sphingolipid pathway WP1422,0.5959595074186679,0.9842364532019704,0.5094236179731624,"['UGT8', 'UGCG', 'SERINC1', 'B4GALT6']",0.9966398380664583,0,0,4
320,Bile acids synthesis and enterohepatic circulation  WP4389,0.60349918882163,1.2304476143630103,0.6213890665497129,['SLC10A1'],0.9966398380664583,0,0,1
321,Classical pathway of steroidogenesis with glucocorticoid and mineralocorticoid metabolism WP4523,0.60349918882163,1.2304476143630103,0.6213890665497129,['HSD11B1'],0.9966398380664583,0,0,1
322,Cytokines and Inflammatory Response WP530,0.60349918882163,1.2304476143630103,0.6213890665497129,['CSF1'],0.9966398380664583,0,0,1
323,Estrogen metabolism WP697,0.60349918882163,1.2304476143630103,0.6213890665497129,['NQO1'],0.9966398380664583,0,0,1
324,FOXP3 in COVID-19 WP5063,0.60349918882163,1.2304476143630103,0.6213890665497129,['STAT3'],0.9966398380664583,0,0,1
325,NAD Biosynthesis II (from tryptophan) WP2485,0.60349918882163,1.2304476143630103,0.6213890665497129,['HAAO'],0.9966398380664583,0,0,1
326,Nephrogenesis WP5052,0.60349918882163,1.2304476143630103,0.6213890665497129,['BMP7'],0.9966398380664583,0,0,1
327,SARS-CoV-2 and COVID-19 Pathway WP4846,0.60349918882163,1.2304476143630103,0.6213890665497129,['NRP1'],0.9966398380664583,0,0,1
328,Serotonin Transporter Activity WP1455,0.60349918882163,1.2304476143630103,0.6213890665497129,['IL1R1'],0.9966398380664583,0,0,1
329,Somatroph axis (GH) and its relationship to dietary restriction and aging WP4186,0.60349918882163,1.2304476143630103,0.6213890665497129,['IGF1R'],0.9966398380664583,0,0,1
330,TCA Cycle Nutrient Utilization and Invasiveness of Ovarian Cancer WP2868,0.60349918882163,1.2304476143630103,0.6213890665497129,['STAT3'],0.9966398380664583,0,0,1
331,Vitamin D Metabolism WP1531,0.60349918882163,1.2304476143630103,0.6213890665497129,['DHCR7'],0.9966398380664583,0,0,1
332,Ebstein-Barr virus LMP1 signaling WP262,0.6072088361817413,0.9842442146725751,0.4910222150810413,"['HSP90AA1', 'TRAF6', 'MAP3K14']",0.9966398380664583,0,0,3
333,Initiation of transcription and translation elongation at the HIV-1 LTR WP3414,0.6192722193438114,0.9462789551503203,0.45346665055943175,"['HEXIM1', 'PPP3CC', 'SUPT4H1', 'NFATC2', 'NFATC1']",0.9966398380664583,0,0,5
334,Signaling of Hepatocyte Growth Factor Receptor WP313,0.6192722193438114,0.9462789551503203,0.45346665055943175,"['ITGB1', 'PAK1', 'HGF', 'STAT3', 'HRAS']",0.9966398380664583,0,0,5
335,AGE/RAGE pathway WP2324,0.6252148631168017,0.937150378413952,0.440141959887665,"['LGALS3', 'SMAD3', 'IRS1', 'SHC1', 'STAT3', 'CYCS', 'PRKCZ', 'SOD1']",0.9966398380664583,0,0,8
336,Pyrimidine metabolism and related diseases WP4225,0.6266059104779719,0.984251968503937,0.4600762479244859,"['NT5C', 'GLS2']",0.9966398380664583,0,0,2
337,Wnt signaling WP428,0.6293471573824312,0.9370260468183317,0.4339107644998441,"['CCND3', 'CCND2', 'WNT2B', 'PPP3CC', 'DAAM1', 'DAAM2', 'WIF1', 'WNT7B', 'CAMK2A', 'NFATC2', 'WNT7A', 'NFATC1']",0.9966398380664583,0,0,12
338,Resistin as a regulator of inflammation WP4481,0.6298350596166066,0.9372742200328408,0.4332993450366193,"['ITPR1', 'PLCG2', 'PIK3CD', 'PLCE1']",0.9966398380664583,0,0,4
339,Phosphodiesterases in neuronal function WP4222,0.638806846940976,0.9225221893491125,0.4134312198030726,"['GUCY1A2', 'GRIN2A', 'CHRNA7', 'PDE5A', 'ADCY2', 'PDE8B']",0.9966398380664583,0,0,6
340,Cannabinoid receptor signaling WP3869,0.6454352909285712,0.9226366322008862,0.4039582920602809,"['PRKAR2B', 'PRKAR1A', 'AHR']",0.9966398380664583,0,0,3
341,Hair Follicle Development: Organogenesis - Part 2 of 3 WP2839,0.6454352909285712,0.9226366322008862,0.4039582920602809,"['ITGB1', 'LAMA5', 'CCND2']",0.9966398380664583,0,0,3
342,Hereditary leiomyomatosis and renal cell carcinoma pathway WP4206,0.6454352909285712,0.9226366322008862,0.4039582920602809,"['LDHA', 'RPS6', 'VEGFA']",0.9966398380664583,0,0,3
343,Immune response to tuberculosis WP4197,0.6454352909285712,0.9226366322008862,0.4039582920602809,"['IFNAR2', 'IFI35', 'IRF9']",0.9966398380664583,0,0,3
344,NAD Metabolism in Oncogene-Induced Senescence and Mitochondrial Dysfunction-Associated Senescence WP5046,0.6454352909285712,0.9226366322008862,0.4039582920602809,"['MDH1', 'MDH2', 'NAMPT']",0.9966398380664583,0,0,3
345,Pre-implantation embryo WP3527,0.6454352909285712,0.9226366322008862,0.4039582920602809,"['ZFP36', 'ATP1A1', 'HNRNPAB']",0.9966398380664583,0,0,3
346,Prostaglandin Synthesis and Regulation WP98,0.6454352909285712,0.9226366322008862,0.4039582920602809,"['HSD11B1', 'EDNRA', 'S100A6']",0.9966398380664583,0,0,3
347,White fat cell differentiation WP4149,0.6454352909285712,0.9226366322008862,0.4039582920602809,"['SREBF1', 'CEBPB', 'CEBPD']",0.9966398380664583,0,0,3
348,Wnt/beta-catenin signaling pathway in leukemia WP3658,0.6454352909285712,0.9226366322008862,0.4039582920602809,"['WIF1', 'ZBTB16', 'PML']",0.9966398380664583,0,0,3
349,Pathways in clear cell renal cell carcinoma WP4018,0.6528413741981183,0.9170890689276707,0.39106612750476955,"['LDHA', 'TPI1', 'MDH1', 'FASN', 'STAT3', 'PGK1', 'ENPP3', 'ENO2', 'RAPGEF5', 'GAPDH', 'VEGFA']",0.9966398380664583,0,0,11
350,Renin-angiotensin-aldosterone system (RAAS) WP4756,0.661828234777516,0.8945812807881773,0.3692377265822721,"['CAMK4', 'CAMK2A', 'ITPR1', 'CALM3']",0.9966398380664583,0,0,4
351,Metabolic reprogramming in colon cancer WP4290,0.6648464052813232,0.8944773175542406,0.3651249563082776,"['LDHA', 'MDH2', 'PGAM1', 'FASN', 'PGK1', 'GAPDH']",0.9966398380664583,0,0,6
352,Regulation of Microtubule Cytoskeleton WP2038,0.6648464052813232,0.8944773175542406,0.3651249563082776,"['PAK1', 'PARD6A', 'MAP1B', 'CAMK4', 'STMN1', 'STAT3']",0.9966398380664583,0,0,6
353,Androgen receptor signaling pathway WP138,0.6669746041167216,0.9080118694362018,0.36774781135057416,"['CDKN1A', 'SMAD3', 'SUMO1', 'LIMK2', 'BAG1', 'STAT3', 'FLNA', 'DSTN', 'STUB1', 'FKBP4', 'RAN', 'RHOB']",0.9966398380664583,0,0,12
354,Aspirin and miRNAs WP4707,0.6704881700665831,0.9842597147073291,0.3934570531001187,['VEGFA'],0.9966398380664583,0,0,1
355,Caloric restriction and aging WP4191,0.6704881700665831,0.9842597147073291,0.3934570531001187,['NAMPT'],0.9966398380664583,0,0,1
356,Disorders of Folate Metabolism and Transport WP4259,0.6704881700665831,0.9842597147073291,0.3934570531001187,['DHFR'],0.9966398380664583,0,0,1
357,Fluoroacetic acid toxicity WP4966,0.6704881700665831,0.9842597147073291,0.3934570531001187,['ACSS2'],0.9966398380664583,0,0,1
358,Folate-Alcohol and Cancer Pathway Hypotheses WP1589,0.6704881700665831,0.9842597147073291,0.3934570531001187,['CEBPB'],0.9966398380664583,0,0,1
359,Genes targeted by miRNAs in adipocytes WP1992,0.6704881700665831,0.9842597147073291,0.3934570531001187,['TMSB4X'],0.9966398380664583,0,0,1
360,LDLRAD4 and what we know about it WP4904,0.6704881700665831,0.9842597147073291,0.3934570531001187,['NEDD4'],0.9966398380664583,0,0,1
361,"Metabolic pathway of LDL, HDL and TG, including diseases WP4522",0.6704881700665831,0.9842597147073291,0.3934570531001187,['APOE'],0.9966398380664583,0,0,1
362,miRNA Biogenesis WP2338,0.6704881700665831,0.9842597147073291,0.3934570531001187,['RAN'],0.9966398380664583,0,0,1
363,"Phase I biotransformations, non P450 WP136",0.6704881700665831,0.9842597147073291,0.3934570531001187,['PON1'],0.9966398380664583,0,0,1
364,Sulfation Biotransformation Reaction WP692,0.6704881700665831,0.9842597147073291,0.3934570531001187,['SULT4A1'],0.9966398380664583,0,0,1
365,Urea cycle and related diseases WP4571,0.6704881700665831,0.9842597147073291,0.3934570531001187,['GLS2'],0.9966398380664583,0,0,1
366,RAC1/PAK1/p38/MMP2 Pathway WP3303,0.6708674148390537,0.8943731490621916,0.3570192319413947,"['ITGB1', 'PAK1', 'STMN1', 'STAT3', 'FN1', 'BAX', 'HRAS', 'ANGPTL1']",0.9966398380664583,0,0,8
367,Airway smooth muscle cell contraction WP4962,0.6713618379137242,0.8946850393700787,0.3564846017506688,"['PPP1R14A', 'CD38']",0.9966398380664583,0,0,2
368,miRNA targets in ECM and membrane receptors WP2911,0.6713618379137242,0.8946850393700787,0.3564846017506688,"['COL4A1', 'FN1']",0.9966398380664583,0,0,2
369,Omega-9 FA synthesis WP4724,0.6713618379137242,0.8946850393700787,0.3564846017506688,"['SCD', 'FASN']",0.9966398380664583,0,0,2
370,PI3K/AKT/mTOR - VitD3 signaling WP4141,0.6713618379137242,0.8946850393700787,0.3564846017506688,"['LDHA', 'SLC2A3']",0.9966398380664583,0,0,2
371,STING pathway in Kawasaki-like disease and COVID-19 WP4961,0.6713618379137242,0.8946850393700787,0.3564846017506688,"['ITPR1', 'F3']",0.9966398380664583,0,0,2
372,TGF-B Signaling in Thyroid Cells for Epithelial-Mesenchymal Transition WP3859,0.6713618379137242,0.8946850393700787,0.3564846017506688,"['SMAD3', 'FN1']",0.9966398380664583,0,0,2
373,Phosphoinositides metabolism WP4971,0.676440180162269,0.8785115820601281,0.34342007013697956,"['PLCG2', 'PIK3CD', 'PIP4K2A', 'PLCE1', 'PIK3C2A']",0.9966398380664583,0,0,5
374,Endothelin Pathways WP2197,0.680943020545393,0.8682770006082197,0.3336585741173311,"['EDNRA', 'CALCRL', 'GNAI1']",0.9966398380664583,0,0,3
375,Extracellular vesicle-mediated signaling in recipient cells WP2870,0.680943020545393,0.8682770006082197,0.3336585741173311,"['SMAD3', 'HGF', 'HRAS']",0.9966398380664583,0,0,3
376,FGFR3 signaling in chondrocyte proliferation and terminal differentiation WP4767,0.680943020545393,0.8682770006082197,0.3336585741173311,"['CDKN1A', 'FGF9', 'FGFR3']",0.9966398380664583,0,0,3
377,Unfolded protein response WP4925,0.680943020545393,0.8682770006082197,0.3336585741173311,"['XBP1', 'TNFRSF10B', 'TXNIP']",0.9966398380664583,0,0,3
378,Head and Neck Squamous Cell Carcinoma WP4674,0.6845012310873826,0.8853333333333333,0.3355987345703696,"['FKBP1A', 'CDKN1A', 'NOTCH1', 'SESN1', 'RPS6', 'HRAS', 'FGFR3', 'IGF1R', 'VEGFA']",0.9966398380664583,0,0,9
379,Cytosolic DNA-sensing pathway WP4655,0.6896695652683018,0.8680821441002436,0.32252957236545976,"['RNF125', 'IL18', 'IRF7', 'POLR2E', 'POLR2K', 'POLR2L']",0.9966398380664583,0,0,6
380,Translation inhibitors in chronically activated PDGFRA cells WP4566,0.6896695652683018,0.8680821441002436,0.32252957236545976,"['EIF4A2', 'RPS6KA2', 'RPS6', 'PIM1', 'PDCD4', 'EIF4B']",0.9966398380664583,0,0,6
381,Base Excision Repair WP4752,0.6918854773184906,0.8556007710430499,0.31514756648777814,"['POLE4', 'POLD4', 'APEX1', 'POLE3']",0.9966398380664583,0,0,4
382,Host-pathogen interaction of human coronaviruses - interferon induction WP4880,0.6918854773184906,0.8556007710430499,0.31514756648777814,"['IFIH1', 'IFNAR2', 'TRAF6', 'IRF9']",0.9966398380664583,0,0,4
383,Rett syndrome causing genes WP4312,0.701784298413439,0.8607548100641342,0.3048184031514631,"['GRIN2A', 'IMPDH2', 'HAP1', 'SMARCA1', 'SCN2A', 'GABRD', 'SYNE2']",0.9966398380664583,0,0,7
384,Chemokine signaling pathway WP3929,0.7033274173167984,0.8885765946400759,0.31271920685954774,"['SHC1', 'STAT3', 'PIK3CD', 'PRKX', 'ADCY2', 'CXCL14', 'PRKCZ', 'CX3CL1', 'GNAI1', 'GNG3', 'PAK1', 'GNG2', 'GRK5', 'PARD3', 'HRAS']",0.9966398380664583,0,0,15
385,Apoptosis WP254,0.712974823069175,0.8553156787844972,0.2893611377665055,"['IRF7', 'TNFRSF10B', 'FAS', 'CYCS', 'BAX', 'BCL2L2', 'IGF1R', 'TNFRSF1A']",0.9966398380664583,0,0,8
386,Modulators of TCR signaling and T cell activation WP5072,0.7132460697820031,0.8431952662721893,0.28493996382150116,"['NDUFB10', 'TRAF6', 'ELOB', 'PRKCQ', 'RNF7', 'MAP3K14']",0.9966398380664583,0,0,6
387,TLR4 Signaling and Tolerance WP3851,0.7137319508294545,0.8199573280814049,0.2765288100208166,"['TRAF6', 'IRF7', 'TAB2']",0.9966398380664583,0,0,3
388,22q11.2 copy number variation syndrome WP4657,0.725696192830002,0.8585159554017685,0.2752606642207782,"['RTN4R', 'ACTA2', 'SREBF1', 'RANBP1', 'AIFM3', 'MRPL40', 'OAT', 'THAP7', 'CHRD', 'HES1', 'RAN']",0.9966398380664583,0,0,11
389,Cell Differentiation - Index WP2029,0.7261639132951112,0.8201344482702082,0.26242622196901066,['STAT3'],0.9966398380664583,0,0,1
390,IL-10 Anti-inflammatory Signaling Pathway  WP4495,0.7261639132951112,0.8201344482702082,0.26242622196901066,['STAT3'],0.9966398380664583,0,0,1
391,Ketogenesis and Ketolysis WP4742,0.7261639132951112,0.8201344482702082,0.26242622196901066,['BDH1'],0.9966398380664583,0,0,1
392,LTF danger signal response pathway WP4478,0.7261639132951112,0.8201344482702082,0.26242622196901066,['TRAF6'],0.9966398380664583,0,0,1
393,Mammary gland development pathway - Embryonic development (Stage 1 of 4) WP2813,0.7261639132951112,0.8201344482702082,0.26242622196901066,['ITGB1'],0.9966398380664583,0,0,1
394,Methionine metabolism leading to sulfur amino acids and related disorders WP4292,0.7261639132951112,0.8201344482702082,0.26242622196901066,['BHMT'],0.9966398380664583,0,0,1
395,Serine Metabolism WP4688,0.7261639132951112,0.8201344482702082,0.26242622196901066,['DHFR'],0.9966398380664583,0,0,1
396,Simplified Depiction of MYD88 Distinct Input-Output Pathway WP3877,0.7261639132951112,0.8201344482702082,0.26242622196901066,['TRAF6'],0.9966398380664583,0,0,1
397,Type III interferon signaling WP2113,0.7261639132951112,0.8201344482702082,0.26242622196901066,['IRF9'],0.9966398380664583,0,0,1
398,Vitamin B12 Disorders WP4271,0.7261639132951112,0.8201344482702082,0.26242622196901066,['CUBN'],0.9966398380664583,0,0,1
399,Glioblastoma signaling pathways WP2261,0.7331143777170247,0.8477579392122121,0.26318946068983573,"['CDKN1A', 'CCND2', 'IRS1', 'PLCG2', 'PIK3CD', 'PRKCQ', 'PIK3C2A', 'HRAS', 'PRKCZ', 'IGF1R']",0.9966398380664583,0,0,10
400,Insulin Signaling WP481,0.7344180749265963,0.8820996853783739,0.2722837329952108,"['SNAP25', 'XBP1', 'ARF1', 'GSK3A', 'IRS1', 'SHC1', 'PIK3CD', 'IRS2', 'PIK3C2A', 'PRKCZ', 'IGF1R', 'SOCS3', 'RPS6KA2', 'FLOT2', 'PRKCQ', 'MAP3K6', 'MAP3K14', 'HRAS', 'VAMP2', 'SH2B2', 'ARF6']",0.9966398380664583,0,0,21
401,G1 to S cell cycle control WP45,0.7355603978972098,0.8196909927679158,0.25174564870332183,"['CDKN2D', 'CDKN1A', 'CCND3', 'CCND2', 'GADD45A', 'RPA3']",0.9966398380664583,0,0,6
402,Brain-derived neurotrophic factor (BDNF) signaling pathway WP2380,0.7419770008635597,0.8726931193617958,0.26044394476956484,"['NSF', 'RAB3A', 'IRS1', 'SHC1', 'RPS6', 'RASGRF1', 'CAMK2A', 'STAT3', 'IRS2', 'EEF2', 'CDK5', 'TRAF6', 'CAMK4', 'CFL1', 'SPP1', 'HRAS', 'GRIA3', 'SH2B2', 'CDK5R1']",0.9966398380664583,0,0,19
403,Overview of leukocyte-intrinsic Hippo pathway functions WP4542,0.7438503887630866,0.7767239368732022,0.22984453931691834,"['RAB13', 'NDRG1', 'TEAD3']",0.9966398380664583,0,0,3
404,Constitutive Androstane Receptor Pathway WP2875,0.7477244765162175,0.7568897637795275,0.22004353388307565,"['HSP90AA1', 'CYP3A5']",0.9966398380664583,0,0,2
405,MAPK pathway in congenital thyroid cancer WP4928,0.7477244765162175,0.7568897637795275,0.22004353388307565,"['GAREM2', 'SHC1']",0.9966398380664583,0,0,2
406,nsp1 from SARS-CoV-2 inhibits translation initiation in the host cell WP5027,0.7477244765162175,0.7568897637795275,0.22004353388307565,"['EIF1AX', 'EIF1']",0.9966398380664583,0,0,2
407,Overview of interferons-mediated signaling pathway WP4558,0.7477244765162175,0.7568897637795275,0.22004353388307565,"['IFNAR2', 'IRF9']",0.9966398380664583,0,0,2
408,Toll-like Receptor Signaling Pathway WP75,0.7513659603010246,0.8195129976966107,0.23426799215694039,"['IFNAR2', 'TICAM2', 'TOLLIP', 'TRAF6', 'IRF7', 'SPP1', 'PIK3CD', 'TAB2']",0.9966398380664583,0,0,8
409,Regulatory circuits of the STAT3 signaling pathway WP4538,0.7628066638848933,0.800461215451865,0.21672540976024943,"['PTPRT', 'IFNAR2', 'SOCS3', 'CTF1', 'STMN1', 'STAT3', 'OSMR']",0.9966398380664583,0,0,7
410,B Cell Receptor Signaling Pathway WP23,0.7662769451890523,0.81933465085639,0.2181164107403729,"['GSK3A', 'BCL6', 'CD81', 'SHC1', 'CAMK2A', 'PLCG2', 'NFATC2', 'GAB2', 'ETS1', 'HRAS']",0.9966398380664583,0,0,10
411,Wnt signaling pathway and pluripotency WP399,0.7662769451890523,0.81933465085639,0.2181164107403729,"['CCND3', 'CCND2', 'WNT2B', 'PPP2R1A', 'FZD4', 'WNT7B', 'WNT7A', 'PRKCQ', 'PRKCZ', 'CD44']",0.9966398380664583,0,0,10
412,DNA Replication WP466,0.7703907710765561,0.7566502463054188,0.19737781441836869,"['POLD4', 'RPA3', 'CDC7', 'UBA52']",0.9966398380664583,0,0,4
413,MTHFR deficiency WP4288,0.7713836260096445,0.7378138847858198,0.19151395147913045,"['GRIN2A', 'BHMT', 'CYCS']",0.9966398380664583,0,0,3
414,Biomarkers for urea cycle disorders WP4583,0.7724362378329308,0.7029021151008362,0.18149341253814863,['GLS2'],0.9966398380664583,0,0,1
415,Cancer immunotherapy by CTLA4 blockade WP4582,0.7724362378329308,0.7029021151008362,0.18149341253814863,['PIK3CD'],0.9966398380664583,0,0,1
416,Estrogen Receptor Pathway WP2881,0.7724362378329308,0.7029021151008362,0.18149341253814863,['STAT3'],0.9966398380664583,0,0,1
417,Iron metabolism in placenta WP2007,0.7724362378329308,0.7029021151008362,0.18149341253814863,['FTH1'],0.9966398380664583,0,0,1
418,Major receptors targeted by epinephrine and norepinephrine WP4589,0.7724362378329308,0.7029021151008362,0.18149341253814863,['ADCY2'],0.9966398380664583,0,0,1
419,Regulation of sister chromatid separation at the metaphase-anaphase transition WP4240,0.7724362378329308,0.7029021151008362,0.18149341253814863,['ANAPC11'],0.9966398380664583,0,0,1
420,SRF and miRs in Smooth Muscle Differentiation and Proliferation WP1991,0.7724362378329308,0.7029021151008362,0.18149341253814863,['CCND2'],0.9966398380664583,0,0,1
421,Trans-sulfuration pathway WP2333,0.7724362378329308,0.7029021151008362,0.18149341253814863,['GCLM'],0.9966398380664583,0,0,1
422,Interleukin-11 Signaling Pathway WP2332,0.7726143757206183,0.7683896007885658,0.19822547783412647,"['SOCS3', 'STAT3', 'RPS6', 'HRAS', 'ICAM1']",0.9966398380664583,0,0,5
423,RANKL/RANK signaling pathway WP2018,0.7764044575051512,0.7763936468389909,0.1964910134953477,"['TRAF6', 'TNFRSF11B', 'NFATC1', 'TAB2', 'GAB2', 'ICAM1']",0.9966398380664583,0,0,6
424,Mitochondrial Gene Expression WP391,0.7798390986024307,0.702755905511811,0.17475266968166983,"['CAMK4', 'TFB2M']",0.9966398380664583,0,0,2
425,"Oligodendrocyte specification and differentiation, leading to myelin components for CNS WP4304",0.7798390986024307,0.702755905511811,0.17475266968166983,"['MOG', 'PLP1']",0.9966398380664583,0,0,2
426,"Relationship between inflammation, COX-2 and EGFR WP4483",0.7798390986024307,0.702755905511811,0.17475266968166983,"['PIK3CD', 'HRAS']",0.9966398380664583,0,0,2
427,Angiopoietin Like Protein 8 Regulatory Pathway WP3915,0.7811168044176087,0.8363874069544314,0.20661326859666906,"['SREBF1', 'GSK3A', 'IRS1', 'SHC1', 'PIK3CD', 'IRS2', 'PIK3C2A', 'SLCO1C1', 'SCD', 'RPS6KA2', 'FASN', 'TRIP10', 'FLOT2', 'MAP3K6', 'MAP3K14', 'HRAS']",0.9966398380664583,0,0,16
428,Endometrial cancer WP4155,0.7859969028581617,0.7865745310957551,0.1894090560607567,"['CDKN1A', 'GADD45B', 'EGF', 'GADD45A', 'PIK3CD', 'BAX', 'HRAS', 'FGFR3']",0.9966398380664583,0,0,8
429,Mesodermal commitment pathway WP2857,0.7928908928992847,0.818976897689769,0.19005968575768786,"['SMAD1', 'SMAD3', 'FZD4', 'CHRD', 'PBX3', 'HMGA2', 'TBX6', 'BMP7', 'ARL4A', 'PRKAR1A', 'SESN1', 'C1QBP', 'RPL38', 'HPRT1']",0.9966398380664583,0,0,14
430,ncRNAs involved in Wnt signaling in hepatocellular carcinoma WP4336,0.7949623755100249,0.7564102564102564,0.17356626947644774,"['CCND3', 'WNT2B', 'CCND2', 'WIF1', 'WNT7B', 'WNT7A']",0.9966398380664583,0,0,6
431,Novel intracellular components of RIG-I-like receptor (RLR) pathway WP3865,0.7949623755100249,0.7564102564102564,0.17356626947644774,"['DDX3Y', 'IFIH1', 'RNF125', 'TRAF6', 'IRF7', 'PIN1']",0.9966398380664583,0,0,6
432,16p11.2 distal deletion syndrome WP4950,0.7964441767610136,0.7026095519448547,0.15991269585718948,"['PLN', 'CD81', 'NFATC2']",0.9966398380664583,0,0,3
433,Leptin signaling pathway WP2034,0.8060621040471208,0.7760623781676413,0.16731477051542507,"['SOCS3', 'GSK3A', 'IRS1', 'SHC1', 'RPS6', 'STAT3', 'PLCG2', 'BAX', 'HRAS']",0.9966398380664583,0,0,9
434,Gastrin signaling pathway WP4659,0.8068337198672199,0.7968562033843933,0.17103536614684833,"['ITGB1', 'CDKN1A', 'PAK1', 'IRS1', 'SHC1', 'RPS6', 'STAT3', 'PRKCQ', 'HRAS', 'CD44', 'RHOB', 'VEGFA']",0.9966398380664583,0,0,12
435,Gastric Cancer Network 1 WP2361,0.8083075762928048,0.6558398950131233,0.13957101236994449,"['NOTCH1', 'GATD3A']",0.9966398380664583,0,0,2
436,Inhibition of exosome biogenesis and secretion by Manumycin A in CRPC cells WP4301,0.8083075762928048,0.6558398950131233,0.13957101236994449,"['MRAS', 'HRAS']",0.9966398380664583,0,0,2
437,Methionine De Novo and Salvage Pathway WP3580,0.8083075762928048,0.6558398950131233,0.13957101236994449,"['BHMT', 'TXN']",0.9966398380664583,0,0,2
438,NAD+ biosynthetic pathways WP3645,0.8083075762928048,0.6558398950131233,0.13957101236994449,"['NAMPT', 'CD38']",0.9966398380664583,0,0,2
439,Purine metabolism and related disorders WP4224,0.8083075762928048,0.6558398950131233,0.13957101236994449,"['GRM5', 'HPRT1']",0.9966398380664583,0,0,2
440,Urea cycle and metabolism of amino groups WP497,0.8083075762928048,0.6558398950131233,0.13957101236994449,"['ARG2', 'OAT']",0.9966398380664583,0,0,2
441,15q13.3 copy number variation syndrome WP4942,0.8108926931727141,0.6149778652238072,0.12891138203655825,['CHRNA7'],0.9966398380664583,0,0,1
442,Ethanol metabolism resulting in production of ROS by CYP2E1 WP4269,0.8108926931727141,0.6149778652238072,0.12891138203655825,['PRKCQ'],0.9966398380664583,0,0,1
443,MFAP5-mediated ovarian cancer cell motility and invasiveness WP3301,0.8108926931727141,0.6149778652238072,0.12891138203655825,['PRKCQ'],0.9966398380664583,0,0,1
444,ncRNAs involved in STAT3 signaling in hepatocellular carcinoma WP4337,0.8108926931727141,0.6149778652238072,0.12891138203655825,['STAT3'],0.9966398380664583,0,0,1
445,NLR Proteins WP288,0.8108926931727141,0.6149778652238072,0.12891138203655825,['ERBIN'],0.9966398380664583,0,0,1
446,Host-pathogen interaction of human coronaviruses - MAPK signaling WP4877,0.8133767442579466,0.7024630541871921,0.1451013843220594,"['IFITM3', 'IFITM2', 'RPS6KA2', 'JUNB']",0.9966398380664583,0,0,4
447,IL-5 signaling pathway WP127,0.8133767442579466,0.7024630541871921,0.1451013843220594,"['GSK3A', 'SHC1', 'STAT3', 'RPS6']",0.9966398380664583,0,0,4
448,p38 MAPK Signaling Pathway WP400,0.8133767442579466,0.7024630541871921,0.1451013843220594,"['SHC1', 'RASGRF1', 'HSPB1', 'HRAS']",0.9966398380664583,0,0,4
449,Parkinson's disease pathway WP2371,0.8133767442579466,0.7024630541871921,0.1451013843220594,"['PINK1', 'UBB', 'CYCS', 'SNCA']",0.9966398380664583,0,0,4
450,AMP-activated protein kinase (AMPK) signaling WP1403,0.8142204621382524,0.7480320027455438,0.15373861284399515,"['SREBF1', 'CDKN1A', 'CRTC2', 'FASN', 'PIK3CD', 'HMGCR', 'EEF2']",0.9966398380664583,0,0,7
451,ErbB signaling pathway WP673,0.8148222295044255,0.7833895706620244,0.16042667830445903,"['CDKN1A', 'PAK1', 'NRG4', 'SHC1', 'EGF', 'CAMK2A', 'PLCG2', 'PIK3CD', 'NRG1', 'PAK3', 'HRAS']",0.9966398380664583,0,0,11
452,BDNF-TrkB Signaling WP3676,0.8191635635478353,0.670605612998523,0.1337667100661758,"['SHC1', 'GAB2', 'HRAS']",0.9966398380664583,0,0,3
453,Amino Acid metabolism WP3925,0.8201289532864006,0.7626053639846744,0.15121983238760892,"['ARG2', 'LDHA', 'BHMT', 'WARS', 'OAT', 'MDH1', 'MDH2', 'P4HA2', 'GCLM']",0.9966398380664583,0,0,9
454,Eukaryotic Transcription Initiation WP405,0.8291533092274345,0.7023164120256283,0.13157912603052488,"['TAF13', 'POLR2E', 'POLR2G', 'POLR2I', 'POLR2K']",0.9966398380664583,0,0,5
455,Integrated breast cancer pathway WP1984,0.8310161656170231,0.8028011898859693,0.14860334202735623,"['BARD1', 'SMAD1', 'GSK3A', 'IRS1', 'GADD45A', 'AHR', 'HMGCR', 'JAKMIP1', 'PML', 'FOSL2', 'VEGFA', 'ITPKC', 'PAK1', 'RASGEF1A', 'BAX', 'FILIP1', 'FAU']",0.9966398380664583,0,0,17
456,Integrated Cancer Pathway WP1971,0.8322645136196152,0.6781722439272975,0.12451579020474994,"['BARD1', 'CDKN1A', 'SMAD3', 'BAX']",0.9966398380664583,0,0,4
457,Gastric Cancer Network 2 WP2363,0.8334448707824155,0.6147883858267716,0.11200689479515492,"['S100A6', 'CACYBP']",0.9966398380664583,0,0,2
458,Integrin-mediated Cell Adhesion WP185,0.8361518675828754,0.7559288537549407,0.1352697058248003,"['VASP', 'ITGB1', 'PAK1', 'CAPNS1', 'CAV3', 'SHC1', 'ITGA3', 'PAK3', 'HRAS', 'VCL']",0.9966398380664583,0,0,10
459,Kisspeptin/kisspeptin receptor system in the ovary WP4871,0.8396855243558365,0.6413846252649156,0.11206774569702123,"['PIK3CD', 'PRKCQ', 'HRAS']",0.9966398380664583,0,0,3
460,Melatonin metabolism and effects WP3298,0.8396855243558365,0.6413846252649156,0.11206774569702123,"['TRAF6', 'CAMK2A', 'APOE']",0.9966398380664583,0,0,3
461,Bone morphogenic protein (BMP) signaling and regulation WP1425,0.8428529176166204,0.5465923375416735,0.09344696258105155,['SMAD1'],0.9966398380664583,0,0,1
462,Dopaminergic Neurogenesis WP2855,0.8428529176166204,0.5465923375416735,0.09344696258105155,['STAT3'],0.9966398380664583,0,0,1
463,Ganglio Sphingolipid Metabolism WP1423,0.8428529176166204,0.5465923375416735,0.09344696258105155,['ST8SIA1'],0.9966398380664583,0,0,1
464,Homologous recombination WP186,0.8428529176166204,0.5465923375416735,0.09344696258105155,['POLD4'],0.9966398380664583,0,0,1
465,"NAD metabolism, sirtuins and aging WP3630",0.8428529176166204,0.5465923375416735,0.09344696258105155,['NAMPT'],0.9966398380664583,0,0,1
466,Purine metabolism WP4792,0.8428529176166204,0.5465923375416735,0.09344696258105155,['HPRT1'],0.9966398380664583,0,0,1
467,TCA cycle in senescence WP5050,0.8428529176166204,0.5465923375416735,0.09344696258105155,['MDH1'],0.9966398380664583,0,0,1
468,Endoplasmic reticulum stress response in coronavirus infection WP4861,0.8452515082335785,0.6827391709106839,0.11478282835959165,"['PPP1R3G', 'PPP1R14A', 'XBP1', 'MAP1LC3A', 'PPP1R3C']",0.9966398380664583,0,0,5
469,Envelope proteins and their potential roles in EDMD physiopathology WP4535,0.8452515082335785,0.6827391709106839,0.11478282835959165,"['SMAD3', 'CFL1', 'ADCY2', 'HRAS', 'SYNE2']",0.9966398380664583,0,0,5
470,Hippo-Yap signaling pathway WP4537,0.855563596551317,0.5785664659564613,0.09025338904545223,"['NDRG1', 'TEAD3']",0.9990794773387612,0,0,2
471,T-Cell Receptor and Co-stimulatory Signaling WP2583,0.855563596551317,0.5785664659564613,0.09025338904545223,"['GSK3A', 'NFATC2']",0.9990794773387612,0,0,2
472,Vitamin D in inflammatory diseases WP4482,0.855563596551317,0.5785664659564613,0.09025338904545223,"['SMAD3', 'NFATC1']",0.9990794773387612,0,0,2
473,16p11.2 proximal deletion syndrome WP4949,0.8567163393321572,0.7147087857847977,0.1105285757521084,"['UNC13A', 'PPP2R1A', 'TRAF6', 'MVP', 'TCP1', 'KIF22', 'TBX6', 'SEZ6L2']",0.9990794773387612,0,0,8
474,Chromosomal and microsatellite instability in colorectal cancer  WP4216,0.8567163393321572,0.7147087857847977,0.1105285757521084,"['CDKN1A', 'SMAD3', 'GADD45B', 'DCC', 'GADD45A', 'CYCS', 'BAX', 'RALGDS']",0.9990794773387612,0,0,8
475,Intraflagellar transport proteins binding to dynein WP4532,0.8581604913850118,0.6145987198424422,0.09401156713957175,"['DYNLT3', 'IFT27', 'DYNLL2']",0.9990794773387612,0,0,3
476,Nucleotide Excision Repair WP4753,0.860074602425789,0.664220159045196,0.10012198719555153,"['POLE4', 'POLD4', 'CETN2', 'RPA3', 'POLE3']",0.9992043175240786,0,0,5
477,Biomarkers for pyrimidine metabolism disorders WP4584,0.8694138319287001,0.49188391539596654,0.06883229257902018,['NT5C'],0.9999843849241683,0,0,1
478,Mammalian disorder of sexual development WP4842,0.8694138319287001,0.49188391539596654,0.06883229257902018,['FGF9'],0.9999843849241683,0,0,1
479,Synaptic signaling pathways associated with autism spectrum disorder WP4539,0.8736883167329464,0.6466758320147338,0.08732166189262036,"['GRIN2A', 'CAMK4', 'PIK3CD', 'HRAS', 'GRM1']",0.9999843849241683,0,0,5
480,Sphingolipid Metabolism (general overview) WP4725,0.8749658343586288,0.5463692038495188,0.0729787748700071,"['UGCG', 'UGT8']",0.9999843849241683,0,0,2
481,Hedgehog Signaling Pathway WP4249,0.8795659391992122,0.6144088669950739,0.07884508945263555,"['EVC2', 'CCND2', 'HHIP', 'BOC']",0.9999843849241683,0,0,4
482,IL-6 signaling pathway WP364,0.8795659391992122,0.6144088669950739,0.07884508945263555,"['SOCS3', 'SHC1', 'STAT3', 'JUNB']",0.9999843849241683,0,0,4
483,PDGF Pathway WP2526,0.8795659391992122,0.6144088669950739,0.07884508945263555,"['PAK1', 'SHC1', 'STAT3', 'HRAS']",0.9999843849241683,0,0,4
484,Regulation of toll-like receptor signaling pathway WP1449,0.8886717036913246,0.7015810276679841,0.08280578378370353,"['IFNAR2', 'TICAM2', 'IRAK2', 'TOLLIP', 'TRAF6', 'IRF7', 'PELI1', 'SPP1', 'PIK3CD', 'TAB2']",0.9999843849241683,0,0,10
485,Fatty acid beta-oxidation WP143,0.8895791904824033,0.5672082717872969,0.06636719518049791,"['ACSS2', 'TPI1', 'ACSL6']",0.9999843849241683,0,0,3
486,PDGFR-beta pathway WP3972,0.8895791904824033,0.5672082717872969,0.06636719518049791,"['SHC1', 'STAT3', 'HRAS']",0.9999843849241683,0,0,3
487,Thymic Stromal LymphoPoietin (TSLP) Signaling Pathway WP2203,0.8895791904824033,0.5672082717872969,0.06636719518049791,"['STAT3', 'RPS6', 'GAB2']",0.9999843849241683,0,0,3
488,Eicosanoid metabolism via lipooxygenases (LOX) WP4721,0.8914872124046592,0.4471224790949336,0.05135835946553316,['ALOX12'],0.9999843849241683,0,0,1
489,Photodynamic therapy-induced unfolded protein response WP3613,0.8919377738908633,0.5175611272275176,0.0591877258751442,"['XBP1', 'WARS']",0.9999843849241683,0,0,2
490,Sphingolipid Metabolism (integrated pathway) WP4726,0.8919377738908633,0.5175611272275176,0.0591877258751442,"['UGT8', 'UGCG']",0.9999843849241683,0,0,2
491,Netrin-UNC5B signaling pathway WP4747,0.9042522303330193,0.5781512605042017,0.05818915618230625,"['UNC5B', 'NTN4', 'CCL2', 'ICAM1']",0.9999843849241683,0,0,4
492,T-Cell antigen Receptor (TCR) pathway during Staphylococcus aureus infection WP3863,0.9042522303330193,0.5781512605042017,0.05818915618230625,"['PAK1', 'NFATC2', 'PRKCQ', 'MAP3K14']",0.9999843849241683,0,0,4
493,Ethanol effects on histone modifications WP3996,0.9067464645424633,0.49163385826771655,0.04812721824320052,"['DHFR', 'ACSS2']",0.9999843849241683,0,0,2
494,Corticotropin-releasing hormone signaling pathway WP2355,0.9072891773505971,0.654820664692333,0.06371015533699259,"['HSP90AA1', 'CAMK2A', 'IL18', 'PLCG2', 'PRKCQ', 'JUNB', 'GNAI1', 'FOSL2']",0.9999843849241683,0,0,8
495,Hedgehog Signaling Pathway Netpath WP47,0.9098309274875551,0.40982128217740615,0.0387266729810863,['SAP18'],0.9999843849241683,0,0,1
496,IL-9 signaling pathway WP22,0.9098309274875551,0.40982128217740615,0.0387266729810863,['STAT3'],0.9999843849241683,0,0,1
497,MAP3K1 role in promoting and blocking gonadal determination WP4872,0.9098309274875551,0.40982128217740615,0.0387266729810863,['FGF9'],0.9999843849241683,0,0,1
498,Omega-3/Omega-6 FA synthesis WP4723,0.9098309274875551,0.40982128217740615,0.0387266729810863,['PLA2G5'],0.9999843849241683,0,0,1
499,PPAR-alpha pathway WP2878,0.9098309274875551,0.40982128217740615,0.0387266729810863,['DBI'],0.9999843849241683,0,0,1
500,Riboflavin and CoQ disorders WP5037,0.9098309274875551,0.40982128217740615,0.0387266729810863,['RFK'],0.9999843849241683,0,0,1
501,LncRNA involvement in canonical Wnt signaling and colorectal cancer WP4258,0.9126390603603078,0.6140285996055227,0.056131307903211476,"['CCND3', 'WNT2B', 'CCND2', 'WIF1', 'WNT7B', 'WNT7A']",0.9999843849241683,0,0,6
502,Male infertility WP4673,0.9138177590025279,0.6595688225538971,0.05944305694742893,"['NQO1', 'BHMT', 'UBE2B', 'PON1', 'FAS', 'AHR', 'TEX15', 'SOD2', 'REC8']",0.9999843849241683,0,0,9
503,ATM Signaling Network in Development and Disease  WP3878,0.9148275534542419,0.5615763546798029,0.04999135729470877,"['CDK5', 'RASGRF1', 'HSPB1', 'CDK5R1']",0.9999843849241683,0,0,4
504,Cardiac Hypertrophic Response WP2795,0.9174172387653878,0.5848529653359619,0.05041017672494139,"['EGF', 'NFATC2', 'NRG1', 'MAP3K14', 'TNFRSF1A']",0.9999843849241683,0,0,5
505,Physiological and pathological hypertrophy of the heart WP1528,0.9196381160870846,0.4681758530183727,0.03922145006528292,"['CTF1', 'STAT3']",0.9999843849241683,0,0,2
506,Glycosaminoglycan degradation WP4815,0.9250749071758338,0.3782587309394983,0.02945900331024166,['IDS'],0.9999843849241683,0,0,1
507,Neurodegeneration with brain iron accumulation (NBIA) subtypes pathway WP4577,0.932897700259781,0.5311143655971242,0.03689106052387858,"['MAP1LC3A', 'GTPBP2', 'CP', 'FTL']",0.9999843849241683,0,0,4
508,Eicosanoid metabolism via cyclooxygenases (COX) WP4719,0.9377427314164702,0.3512051155927201,0.02257533879647693,['PLA2G5'],0.9999843849241683,0,0,1
509,TCA Cycle and Deficiency of Pyruvate Dehydrogenase complex (PDHc) WP2453,0.9377427314164702,0.3512051155927201,0.02257533879647693,['MDH1'],0.9999843849241683,0,0,1
510,Triacylglyceride synthesis WP325,0.9377427314164702,0.3512051155927201,0.02257533879647693,['MOGAT1'],0.9999843849241683,0,0,1
511,Glycosylation and related congenital defects WP4521,0.9405482510359722,0.42737932214994867,0.026195073575192438,"['SRD5A3', 'MGAT2']",0.9999843849241683,0,0,2
512,Host-pathogen interaction of human coronaviruses - apoptosis WP4864,0.9482695782757743,0.3277586489588457,0.017409376506151975,['BAX'],0.9999843849241683,0,0,1
513,Transcription co-factors SKI and SKIL protein partners WP4533,0.9482695782757743,0.3277586489588457,0.017409376506151975,['TEAD3'],0.9999843849241683,0,0,1
514,Circadian rhythm related genes WP3594,0.9489058261878323,0.6686478454680534,0.03506771773723355,"['SREBF1', 'KCNH7', 'AHR', 'PML', 'CST3', 'DBP', 'NFIL3', 'ID2', 'NOCT', 'NAMPT', 'ID3', 'FAS', 'RPS27A', 'UBA52', 'SKP1']",0.9999843849241683,0,0,15
515,MicroRNAs in cardiomyocyte hypertrophy WP1544,0.9499586378448358,0.5726854135832922,0.029399856266824228,"['CTF1', 'EGF', 'STAT3', 'PIK3CD', 'NRG1', 'MAP3K14', 'IGF1R']",0.9999843849241683,0,0,7
516,Kallmann's Syndrome WP5074,0.9570171429784932,0.3072429906542056,0.01349840569871926,['PRKCQ'],0.9999843849241683,0,0,1
517,Pathways affected in adenoid cystic carcinoma WP3651,0.9627427706769693,0.5009505034147715,0.0190205973536856,"['MORF4L1', 'NOTCH1', 'MYCBP', 'ERBIN', 'HRAS']",0.9999843849241683,0,0,5
518,Follicle Stimulating Hormone (FSH) signaling pathway WP2035,0.9642860415633021,0.2891409392089349,0.01051527665825992,['RPS6'],0.9999843849241683,0,0,1
519,Hematopoietic Stem Cell Gene Regulation by GABP alpha/beta Complex WP3657,0.9642860415633021,0.2891409392089349,0.01051527665825992,['ETV6'],0.9999843849241683,0,0,1
520,Host-pathogen interaction of human coronaviruses - autophagy WP4863,0.9642860415633021,0.2891409392089349,0.01051527665825992,['MAP1LC3A'],0.9999843849241683,0,0,1
521,TCA Cycle (aka Krebs or citric acid cycle) WP78,0.9642860415633021,0.2891409392089349,0.01051527665825992,['MDH2'],0.9999843849241683,0,0,1
522,ATM Signaling Pathway WP2516,0.9678844617159544,0.3639180519101779,0.01187921559294245,"['CDKN1A', 'GADD45A']",0.9999843849241683,0,0,2
523,miRNA regulation of prostate cancer signaling pathways WP3981,0.9678844617159544,0.3639180519101779,0.01187921559294245,"['CDKN1A', 'PLCL2']",0.9999843849241683,0,0,2
524,Glycerolipids and Glycerophospholipids WP4722,0.9703261205765932,0.2730502268131388,0.008225107603372925,['PNPLA3'],0.9999843849241683,0,0,1
525,IL-7 signaling pathway WP205,0.9703261205765932,0.2730502268131388,0.008225107603372925,['STAT3'],0.9999843849241683,0,0,1
526,Signal Transduction of S1P Receptor WP26,0.9703261205765932,0.2730502268131388,0.008225107603372925,['GNAI1'],0.9999843849241683,0,0,1
527,Nanoparticle triggered autophagic cell death WP2509,0.9753450279862693,0.2586532736169001,0.006457019216963408,['MAP1LC3A'],0.9999843849241683,0,0,1
528,Fluoropyrimidine Activity WP1601,0.9795153375482916,0.2456960157402853,0.005085264581511864,['DHFR'],0.9999843849241683,0,0,1
529,TNF related weak inducer of apoptosis (TWEAK) Signaling Pathway WP2036,0.9799554413723554,0.3274278215223097,0.006629816268351376,"['CCL2', 'MAP3K14']",0.9999843849241683,0,0,2
530,Energy Metabolism WP1541,0.9810955893897624,0.3776464795667159,0.007207527852014716,"['PPP3CC', 'CAMK4', 'TFB2M']",0.9999843849241683,0,0,3
531,Target Of Rapamycin (TOR) Signaling WP1471,0.9828965707414898,0.3168338836677673,0.005465822463729483,"['FKBP1A', 'HMGCR']",0.9999843849241683,0,0,2
532,Acute viral myocarditis WP4298,0.9834388188614708,0.40894909688013137,0.006829388841889602,"['STAT3', 'CYCS', 'BAX', 'ACTB']",0.9999843849241683,0,0,4
533,DNA IR-double strand breaks and cellular response via ATM WP3959,0.9836210627957084,0.36816838995568685,0.006080137082592061,"['CDK5', 'TRAF6', 'BAX']",0.9999843849241683,0,0,3
534,Wnt Signaling Pathway WP363,0.9836210627957084,0.36816838995568685,0.006080137082592061,"['GSK3A', 'SOX1', 'NFATC2']",0.9999843849241683,0,0,3
535,Copper homeostasis WP3286,0.9854164808545854,0.30690206692913385,0.004508668794053271,"['ATOX1', 'SOD1']",0.9999843849241683,0,0,2
536,3q29 copy number variation syndrome WP4906,0.9855069765610823,0.40056298381421535,0.005847848323835967,"['DYNLT3', 'PIGM', 'SLC51A', 'DYNLL2']",0.9999843849241683,0,0,4
537,Thyroid hormones production and their peripheral downstream signaling effects WP4746,0.9876309670710378,0.4228344181778012,0.005262667409344212,"['SLCO1C1', 'NOTCH1', 'RPS6', 'PRKCQ', 'HRAS']",0.9999843849241683,0,0,5
538,Glycerophospholipid Biosynthetic Pathway WP2533,0.9882518364367775,0.21358455056780512,0.002524082102163268,['PIK3CD'],0.9999843849241683,0,0,1
539,Endoderm differentiation WP2853,0.9889109503551848,0.5011111111111111,0.005587885740072136,"['NOTCH1', 'SMAD3', 'SESN1', 'C1QBP', 'TCEAL2', 'PBX3', 'HPRT1', 'BMP7', 'NME1']",0.9999843849241683,0,0,9
540,PI3K-AKT-mTOR signaling pathway and therapeutic opportunities WP3844,0.9902394395663947,0.20466469913100507,0.0020074551235585354,['HRAS'],0.9999843849241683,0,0,1
541,Nuclear receptors WP170,0.9932628694889886,0.18888342351205115,0.0012768382343452823,['RXRG'],0.9999843849241683,0,0,1
542,Prion disease pathway WP3995,0.9932628694889886,0.18888342351205115,0.0012768382343452823,['STAT3'],0.9999843849241683,0,0,1
543,Histone Modifications WP2369,0.9934888343192716,0.26529580761864224,0.0017330331334560994,"['H3F3B', 'SMYD2']",0.9999843849241683,0,0,2
544,Thermogenesis WP4321,0.9939898162044226,0.4341203874279505,0.002617015591684518,"['RPS6KA2', 'RPS6', 'ACSL6', 'ADCY2', 'HRAS', 'ACTB', 'ACTG1']",0.9999843849241683,0,0,7
545,Tumor suppressor activity of SMARCB1 WP4204,0.9953498233966401,0.17535661583866208,0.0008173410987374742,['H3F3B'],0.9999843849241683,0,0,1
546,DNA IR-damage and cellular response via ATR WP4016,0.9963474172801908,0.3323369792101528,0.0012161106342831575,"['BARD1', 'BCL6', 'EEF1E1', 'PML']",0.9999843849241683,0,0,4
547,MAPK Cascade WP422,0.9973332840226784,0.15833901908826936,0.00042280919895674676,['HRAS'],0.9999843849241683,0,0,1
548,Joubert Syndrome WP4656,0.9984530313389686,0.30147783251231525,0.0004667378664701417,"['TMEM17', 'CETN2', 'ARL2', 'FLNA']",0.9999843849241683,0,0,4
549,mRNA Processing WP411,0.9986300236969001,0.4288884266000971,0.0005879698255031064,"['SF3B5', 'LSM7', 'SNRPN', 'SNRPD2', 'CELF4', 'SNU13', 'HNRNPH2', 'U2AF1', 'HNRNPA1', 'HNRNPAB']",0.9999843849241683,0,0,10
550,Genes related to primary cilium development (based on CRISPR) WP4536,0.9995950191923647,0.31894777463339335,0.00012919388965350646,"['EVC2', 'MKKS', 'TMEM17', 'SCLT1', 'IFT27', 'KATNB1']",0.9999843849241683,0,0,6
551,DNA Repair Pathways Full Network WP4946,0.9998215417959747,0.2992392223161454,5.340645974065828e-05,"['POLE4', 'POLD4', 'CETN2', 'RPA3', 'APEX1', 'POLE3']",0.9999843849241683,0,0,6
552,Ciliary landscape WP4352,0.9999008903000073,0.42814667988107036,4.243559192002049e-05,"['NDUFA5', 'WHRN', 'DYNLT3', 'CAMK2A', 'COPS7A', 'MYL6B', 'COX6C', 'DYNLL2', 'LSM4', 'MYL6', 'CDH23', 'NEFL', 'IFT27', 'NEFM', 'COPS8', 'MAPRE2']",0.9999843849241683,0,0,16
553,Ciliopathies WP4803,0.9999843849241683,0.30450617283950615,4.754924104456069e-06,"['EVC2', 'MKKS', 'TMEM17', 'SCLT1', 'SPAG1', 'IFT27', 'PKD1L1', 'CCDC65', 'CFAP53']",0.9999843849241683,0,0,9
